<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27092043</article-id>
<article-id pub-id-type="pmc">4824761</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2016.00133</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Psychiatry</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Nespoli</surname>
<given-names>Ester</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/275857/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rizzo</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/289952/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boeckers</surname>
<given-names>Tobias M.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/283143/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hengerer</surname>
<given-names>Bastian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/332717/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ludolph</surname>
<given-names>Andrea G.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Competence in Neuro Spine Department, Boehringer Ingelheim Pharma GmbH &amp; Co. KG</institution>
<country>Biberach an der Riss, Germany</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Child and Adolescence Psychiatry/Psychotherapy, University of Ulm</institution>
<country>Ulm, Germany</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Institute of Anatomy and Cell Biology, University of Ulm</institution>
<country>Ulm, Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Peristera Paschou, Democritus University of Thrace, Greece</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Izhar Bar-Gad, Bar-Ilan University, Israel; Kirsten R. Müller-Vahl, Medical School of Hannover, Germany</p>
</fn>
<corresp id="fn001">*Correspondence: Ester Nespoli <email xlink:type="simple">ester.nespoli@uni-ulm.de</email>;</corresp>
<corresp id="fn002">Francesca Rizzo <email xlink:type="simple">francesca.rizzo@uni-ulm.de</email></corresp>
<fn fn-type="other" id="fn003">
<p>This article was submitted to Child and Adolescent Psychiatry, a section of the journal Frontiers in Neuroscience</p>
</fn>
<fn fn-type="other" id="fn004">
<p>†These authors have contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>10</volume>
<elocation-id>133</elocation-id>
<history>
<date date-type="received">
<day>04</day>
<month>12</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Nespoli, Rizzo, Boeckers, Hengerer and Ludolph.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Nespoli, Rizzo, Boeckers, Hengerer and Ludolph</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Tourette's syndrome (TS) is a neurodevelopmental disorder characterized by fluctuating motor and vocal tics, usually preceded by sensory premonitions, called premonitory urges. Besides tics, the vast majority—up to 90%—of TS patients suffer from psychiatric comorbidities, mainly attention deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). The etiology of TS remains elusive. Genetics is believed to play an important role, but it is clear that other factors contribute to TS, possibly altering brain functioning and architecture during a sensitive phase of neural development. Clinical brain imaging and genetic studies have contributed to elucidate TS pathophysiology and disease mechanisms; however, TS disease etiology still is poorly understood. Findings from genetic studies led to the development of genetic animal models, but they poorly reflect the pathophysiology of TS. Addressing the role of neurotransmission, brain regions, and brain circuits in TS disease pathomechanisms is another focus area for preclinical TS model development. We are now in an interesting moment in time when numerous innovative animal models are continuously brought to the attention of the public. Due to the diverse and largely unknown etiology of TS, there is no single preclinical model featuring all different aspects of TS symptomatology. TS has been dissected into its key symptomst hat have been investigated separately, in line with the Research Domain Criteria concept. The different rationales used to develop the respective animal models are critically reviewed, to discuss the potential of the contribution of animal models to elucidate TS disease mechanisms.</p>
</abstract>
<kwd-group>
<kwd>tics</kwd>
<kwd>repetitive behavior</kwd>
<kwd>genetics</kwd>
<kwd>environment</kwd>
<kwd>PPI</kwd>
<kwd>TS comorbidities</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">European Commission Seventh Framework Programme<named-content content-type="fundref-id">10.13039/501100004963</named-content></funding-source>
<award-id rid="cn001">316978</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="4"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="191"></ref-count>
<page-count count="17"></page-count>
<word-count count="13632"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<sec>
<title>TS definition, epidemiology, symptoms, and natural course</title>
<p>Tourette's Syndrome (TS) was named after Georges Gilles de la Tourette (1857–1904) who first described it as a “tic syndrome” in 1885 and whose observations are still considered mostly valid today. Tics are involuntary movements or vocalizations that can involve different parts of the body changing in frequency, intensity and duration. A diagnose of TS requires the presence of both multiple motor and one or more vocal tics with an onset before age 18 years and a persistence for at least 1 year (DSM-5).</p>
<p>But TS is not only about tics: up to 90% of all TS patients experience psychiatric comorbidities, mainly Attention Deficit/Hyperactivity Disorder (ADHD) and obsessive compulsive disorder (OCD), but also depression, anxiety disorders, conduct disorders, personality disorders, and self-injurious behaviors (Khalifa and Knorring, <xref ref-type="bibr" rid="B76">2007</xref>; Cavanna et al., <xref ref-type="bibr" rid="B31">2009</xref>; Pallanti et al., <xref ref-type="bibr" rid="B114">2011</xref>).</p>
<p>TS has long been considered to be rare, as it was reported to affect only 1 in 2000 (Bruun, <xref ref-type="bibr" rid="B22">1984</xref>). Nowadays the prevalence of TS in the general population has been re-evaluated, and is estimated to be 0.4–1% (Robertson et al., <xref ref-type="bibr" rid="B133">2009</xref>), but could be even higher since, especially in childhood, tics are often so mild that are hardly perceived and easily overlooked. In many cases only an expert eye is able to identify tics in patients presented to the clinician as a consequence of behavioral problems or ADHD.</p>
<sec>
<title>Role of CSTC circuitry in TS pathophysiology</title>
<p>The exact neurobiological background of TS remains still unclear, but a central role of the cortico-striato-thalamo-cortical (CSTC) circuit appears uncontroversial, as numerous anatomical and functional imaging studies were able to detect morphological and functional alterations in CSTC components of TS patients compared to controls (Singer et al., <xref ref-type="bibr" rid="B151">1993</xref>; Peterson et al., <xref ref-type="bibr" rid="B121">2003</xref>; Sowell et al., <xref ref-type="bibr" rid="B154">2008</xref>).</p>
<p>The pre-motor and motor cortices, the striatum, composed of caudate and putamen, the globus pallidus internus (GPi) and externus (GPe), the subthalamic nucleus (STN), the thalamus, and the substantia nigra (SN) are connected in the CSTC circuit. Under physiological circumstances, an activation of this circuit physiologically results in voluntary movements, while involuntary movements are repressed.</p>
<p>Movements occur as the motor cortex is activated by the thalamus, which is controlled by the STN-GPe-GPi microcircuit. When the pre-motor cortex activates the putamen, the inhibitory striatal projection neurons release the thalamus from inhibition held by the STN-GPe-GPi, and eventually the motor cortex can be activated, leading to movement (Obeso and Lanciego, <xref ref-type="bibr" rid="B108">2011</xref>).</p>
<p>Tics are supposed to be caused by a deregulated activity of the basal ganglia, which consequentially leads to disinhibition of the thalamus and a hyperexcitability of the motor cortex (Albin and Mink, <xref ref-type="bibr" rid="B3">2006</xref>; Wang et al., <xref ref-type="bibr" rid="B174">2011</xref>).</p>
<p>When the beneficial effect of dopaminergic modulators such as haloperidol and pimozide on tic management was observed, a dysfunction in the dopaminergic system was seen as the main responsible of TS neuropathology (for review see Buse et al., <xref ref-type="bibr" rid="B23">2013</xref>). Nowadays the use of haloperidol and pimozide has been gradually left aside in favor of the better tolerable atypical antipsychotics and atypical neuroleptics, such as aripiprazole or risperidone, acting on dopamine and serotonin. In general, there is growing evidence indicating that TS is not a pure DA-related disorder, and the interplay of other neurotransmitters is strongly supported to contribute or cause the disease (for review see Udvardi et al., <xref ref-type="bibr" rid="B169">2013</xref>; Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Structure and compartments of CSTC circuit</bold>. <bold>(A)</bold> Representation of a left side of human brain coronal section depicting the anatomical localization of the basal ganglia components and the cerebral cortex. <bold>(B)</bold> Schematic illustration of the CSTC internal network within the circuit depicting the glutamatergic (red arrow), GABAergic (blue arrow) and the dopaminergic connection (yellow arrow). Abbreviations: GPe, Globus Pallidus pars externa; GPi, Globus Pallidus pars interna; STN, Nucleus Subtalamicus; SNc, Substantia Nigra pars compacta; SNr, Substantia Nigra pars reticulata.</p>
</caption>
<graphic xlink:href="fnins-10-00133-g0001"></graphic>
</fig>
</sec>
<sec>
<title>Importance of a TS animal model</title>
<p><italic>In vivo</italic> animal models are important tools to challenge and validate pathophysiological hypotheses and test new therapeutic options. An animal model is constructed to fulfill one or more of the following parameters: <italic>face validity</italic> (ability to show similar symptoms to the patients' ones), <italic>construct validity</italic> (model developed according to a rationale matching the pathological hypothesis), and <italic>predictive validity</italic> (model responds to a treatment similarly to patients). The ideal model is able to show all these three features, but in most cases the main focus remains on one of the three aspects. The use of animal models could help the major means of investigations of TS thanks to their ability to verify pathophysiological hypotheses and test pharmacological compounds.</p>
</sec>
</sec>
</sec>
<sec id="s2" sec-type="methods">
<title>Methods</title>
<p>This article is a review about the “<italic>now-in-use”</italic> preclinical models of TS, extracted from the literature of the last decade. As a perfect model for TS has not yet been produced, we aim at showing the different successful methods used by researchers to independently model all major aspects involved in TS pathology, that we separately describe and analyze. Strengths and limitations of animal models are explained with a focus on recent research findings. The aim is to provide up-to-date information on TS animal models for students, researchers, and clinicians, and hints to be used by preclinical experimenter in developing new TS animal models.</p>
<p>Electronic literature search via MEDLINE/PubMed has been conducted for articles that had been published in English since year 2000. Combinations of keywords were used to identify relevant articles, including: “Tourette Syndrome,” “TS animal model,” “TS <italic>in vivo</italic>,” “motor tic,” “stereotype,” “premonitory urge,” “PPI,” “genetic TS,” “environment TS,” “immune TS,” “ADHD,” “TS neurobiology,” “OCD.” Systematic and narrative reviews, as well as original research articles were included. The last search was conducted on November 2015. The literature search was also supplemented with key publications and book chapters known to the authors.</p>
</sec>
<sec id="s3">
<title>TS phenomenology</title>
<sec>
<title>Genetics</title>
<p>TS has a strong genetic basis. Family studies in children with TS reveal that 8–57% of their parents had a history of tics, and first-degree relatives had a significant increased risk of developing the disorder (Pauls et al., <xref ref-type="bibr" rid="B118">1991</xref>). Twin studies also report a 53–56% concordance rate for TS in monozygotic twins, compared with only 8% in dizygotic twins (Price et al., <xref ref-type="bibr" rid="B128">1985</xref>; Hyde et al., <xref ref-type="bibr" rid="B68">1992</xref>).</p>
<p>The initial idea of TS being a monogenic Mendelian disorder has been quickly revised and TS is now considered a complex disorder with many open questions regarding its overall genomic architecture. The identification of TS-related genes through linkage and association studies is hindered by the unclear mode of inheritance, the genetic heterogeneity of the disease and its apparently incomplete penetrance (Pauls, <xref ref-type="bibr" rid="B117">2003</xref>).</p>
<p>Specific genetic abnormalities have so far been identified in less than 1% of patients, including polymorphisms and copy number variation. Many of these findings also parallel those of other common neuropsychiatric and neurodevelopmental disorders, unveiling previously unknown disease mechanisms, but their specific role for TS has rarely been elucidated (Sundaram et al., <xref ref-type="bibr" rid="B159">2010</xref>; Crane et al., <xref ref-type="bibr" rid="B41">2011</xref>; Scharf et al., <xref ref-type="bibr" rid="B141">2013</xref>; Bertelsen et al., <xref ref-type="bibr" rid="B14">2015</xref>).</p>
<sec>
<title>Modeling TS genetics</title>
<p>Animal genetic manipulation has widely been a key starting point to model numerous diseases.</p>
<p>Sequence variants in <italic>Slirtk 1</italic> were found in TS patients and associated to loss of function in supporting dendritic growth during development of numerous components of CSTC circuit (Abelson et al., <xref ref-type="bibr" rid="B1">2005</xref>). <italic>Slitrk1</italic> KO mice exhibit elevated anxiety- and depression–like behaviors, symptoms which have also been associated withTS-spectrum disorder (Katayama et al., <xref ref-type="bibr" rid="B74">2010</xref>).</p>
<p>The discovery of a mutation in the histidine decarboxylase (<italic>Hdc</italic>) gene in a unique family with marked history of tic disorders lead to the investigation of the disruption of histaminergic pathway in animal models. The core phenomenology of TS, tic-like behaviors, are not observed in <italic>Hdc</italic> KO mice at baseline, but stereotypies as repetitive sniffing and orofacial movements can be elicited by activating the dopamine system with D-amphetamine and are ameliorated after intracerebral administration of dopamine antagonist haloperidol. Fear conditioning significantly increased grooming in these animals (Castellan Baldan et al., <xref ref-type="bibr" rid="B28">2014</xref>)<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>.</p>
<p>Furthermore, significant pre-pulse inhibition (PPI) deficits and striatal dopamine dysregulation have also been observed in <italic>Hdc</italic> KO mice, aligning human findings and supporting the interplay between histamine and dopamine, the major known player in TS (Rapanelli et al., <xref ref-type="bibr" rid="B131">2014</xref>; Xu et al., <xref ref-type="bibr" rid="B183">2015a</xref>).</p>
<p>Another recent genetic TS animal model has been developed based onthe observation that cholinergic interneurons are reduced by 50% in TS patient's striatum (Kataoka et al., <xref ref-type="bibr" rid="B73">2010</xref>; Lennington et al., <xref ref-type="bibr" rid="B87">2014</xref>): region-specific knockout of choline acetyltransferase in the dorsolateral striatum led to stress-induced increase in grooming. D-amphetamine administration did not increase the amount of grooming activity, but the animals performed more repetitive stereotyped actions (Xu et al., <xref ref-type="bibr" rid="B182">2015b</xref>)<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref>.</p>
<p>A main regulator of striatal activity is dopaminergic system whose alterations have been correlated with TS severity and the development of comorbidities. Genetic manipulation has been used as tool to address dopaminergic contribution to the pathology, even though genetic evidence for dopaminergic dysfunction has not been found in TS patients yet. Dopamine transporter (<italic>DAT</italic>) KO mice (Berridge et al., <xref ref-type="bibr" rid="B13">2005</xref>) and dopamine receptor 3 (<italic>DR3</italic>) KO mice (Garner and Mason, <xref ref-type="bibr" rid="B53">2002</xref>) are characterized by a hyperdopaminergic condition and show stereotypies, consolidating their role in repetitive behavior. Furthermore, <italic>DAT</italic> KO mice show a more complex and rigid sequence of actions during grooming, which is in between tics of TS and compulsions of OCD.</p>
<p>The lack of a clear, spontaneous “ticcing” phenotype in these genetic animal models raises the question of further neurotransmitters, synaptic, or developmental mechanisms that need to be evaluated (Table <xref ref-type="table" rid="T1">1</xref>).</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>Genetic animal models of TS</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Transgenic Model</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene target</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Association to TS</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Slitrk1 KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">SLIT and NTRK-like protein1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Slitrk1 mutated variants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Anxiety-like and depression-like behavioral abnormalities attenuated by clonidine (α2 adrenergic agonist) treatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">Katayama et al., <xref ref-type="bibr" rid="B74">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">HDC-KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Histidine Decarboxylase</td>
<td align="left" colspan="1" rowspan="1" valign="top">HDC nonsense mutation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased grooming after D- amphetamine (5-HTR agonist) administration or stress. Stereotypies in HDC KO mice are mitigated by haloperidol (DA agonist) pretreatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">Castellan Baldan et al., <xref ref-type="bibr" rid="B28">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ChAT-ablated mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Choline acetyltransferase</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reduced cholinergic interneurons in striatum of TS patients</td>
<td align="left" colspan="1" rowspan="1" valign="top">No tic-like stereotypies and PPI deficit at baseline; increased and fragmented grooming after acoustic startle stimuli; increased stereotypies after amphetamine (5-HTR agonist) administration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Xu et al., <xref ref-type="bibr" rid="B182">2015b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DAT-KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperdopaminergia in striatum and supestereotypies.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Berridge et al., <xref ref-type="bibr" rid="B13">2005</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">DA/5-HT imbalance in basal ganglia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pogorelov et al., <xref ref-type="bibr" rid="B124">2005</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PPI deficits and perseverative motor patterns</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ralph et al., <xref ref-type="bibr" rid="B130">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DRD3-KO mouse</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D3</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increase in spontaneous stereotypies</td>
<td align="left" colspan="1" rowspan="1" valign="top">Garner and Mason, <xref ref-type="bibr" rid="B53">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperlocomotor activity after amphetamine (5-HTR agonist) treatment</td>
<td align="left" colspan="1" rowspan="1" valign="top">McNamara et al., <xref ref-type="bibr" rid="B102">2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DRD3-KO rat</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hyperactivity and rotational behaviors</td>
<td colspan="1" rowspan="1"></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>List of TS animal models obtained through genetic manipulation. Note that not all human genetic mutations known to have a role in TS have been used to create a valid TS preclinical model. On the other hand, several transgenic animal models have shown a TS-related phenotype but no correlation with a known TS mutation has been found so far. Abbreviations: 5HT2c-KO, Serotonin receptor knock out; CNTNAP2, Contactin-associated protein-like2; COL27A1, Type XXVII collagen alpha chain gene; CRL, controls; DAT-KO, Dopamine transporter knock out; DAT-KD, Dopamine transporter knock down; DRD1-KD, Dopamine receptor D1 knock down; DRD3-KO, Dopamine receptor D3 knock out; GABRB3, GABA A-receptor beta-3; HDC, Histidine decarboxylase; IMMP2L, Inner mitochondrial membrane peptidase; NLGN4X, Neuroligin-4 protein; POLR3B, polymerase (RNA) III (DNA directed) polypeptide B; PPI, Pre-pulse Inhibition; SLITRK1, SLIT and NTRK-like protein1; 5-HTR, serotonin receptor</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Tics</title>
<p>A tic is a sudden, rapid, recurrent, non-rhythmic, jerk-like movement, or vocalization that can vary in frequency, intensity, duration and anatomical localization. Tics are classified as simple or complex according to the number of groups of muscles involved, and as motor or vocal tics.</p>
<p>Simple tics usually last few milliseconds engage one or a group of muscles like those involved in eye blinking (simple motor tic) or throat clearing (simple vocal tics). Complex tics last few seconds and can be defined as a combination of simple tics. They can appear purposeful like performing obscene gesture (copropraxia) or uttering racial slurs (coprolalia) or may consist in the imitation of someone elses′ actions (echopraxia) or words (echolalia).</p>
<p>Three different tic disorders are included in the DSM-5<italic>:</italic> provisional tic disorder, persistent motor, or vocal tic disorder and TS. The difference between these disorders relies on the type of tics observed (motor, vocal, or both), and how long the symptoms have lasted. The presence of both motor and vocal tics for a period longer then 1 year since first onset (before 18 years of age) and their “waxing and waning” course differentiate TS. Indeed, they may show a pattern in which old and new tics overcome and fluctuate in frequency and intensity over time.</p>
<p>Other hyperkinetic movements can occur in TS patients and can be easily misdiagnosed and lead to a wrong treatment approach (Kompoliti and Goetz, <xref ref-type="bibr" rid="B80">1998</xref>). This is the case of stereotypies that are fixed, prolonged and rhythmic repetitive behaviors and present an average age of onset of 3 years (DSM-5). Unlike stereotypies, tics are tipically preceded by an uncomfortable phenomenon called “premonitory urge” (PU) and can be voluntarily suppressed by most patients for a short period of time.</p>
<p>In general, tics are intensified by stress, anxiety, excitement, anger, fatigue, or infections (Lombroso et al., <xref ref-type="bibr" rid="B90">1991</xref>; Nelson, <xref ref-type="bibr" rid="B105">1993</xref>; Lin et al., <xref ref-type="bibr" rid="B89">2007</xref>) while their reduction is reported in patients performing focused and effortful activities (Conelea and Woods, <xref ref-type="bibr" rid="B37">2008</xref>).</p>
<sec>
<title>Modeling Tics</title>
<p>The clear terminology available for clinicians to identify motor disorders is not easily applicable by <italic>in vivo</italic> experimenters, as any parallelism between human and animal condition must be taken carefully.</p>
<p>Literature testifies the lack homogeneity employed to name motor phenotypes in animal models of TS, ranging from “tic,” to “tic-like movement,” or “repetitive movements” and “stereotypies.”</p>
<p>Several animal models of tics have been obtained through systemic or focal administration of active substances, which give a transient but easy to replicate phenotype. Importantly, different compounds with diverse effects were proven to be effective in the induction of tic-like behavior.</p>
<p>The intracerebral infusion of GABAergic antagonists is becoming a more and more appealing strategy of tic-like movement induction and has led to the formulation of the hypothesis that disequilibrium between cortical glutamatergic output and striatal GABAergic metabolism plays an important role in tic induction. The GPe was one of the first basal ganglia components to be investigated with this approach (Grabli et al., <xref ref-type="bibr" rid="B55">2004</xref>), but is now the functional disruption of the striatum to be the major target of investigation.</p>
<p>Striatal injections of the GABAergic antagonist bicuculline in primates cause simple tic-like movements, hyperactivity and stereotyped behaviors (McCairn et al., <xref ref-type="bibr" rid="B100">2009</xref>). These three phenotypes are independent processes and appear to be associated with different brain regions: the sensorimotor network, the prefrontal cortex and associative territories and the orbitofrontal cortex and limbic part of the basal ganglia respectively (Worbe et al., <xref ref-type="bibr" rid="B180">2013</xref>). Electrophysiological data also suggest a role for the cerebellum in tic expression in this model (McCairn et al., <xref ref-type="bibr" rid="B99">2013</xref>). The application of the same approach in adult rats results in an acute tic session that varies in intensity and body parts involved and is characterized by additional hyperactivity (Bronfeld et al., <xref ref-type="bibr" rid="B20">2013</xref>)<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref>. In mice, tics were also evoked by striatal picrotoxin injections, while cortical injections induce seizures (Pogorelov et al., <xref ref-type="bibr" rid="B123">2015</xref>)<xref ref-type="fn" rid="fn0004"><sup>4</sup></xref>.</p>
<p>Systemic administration of hallucinogens acting on serotonin receptors (Tizabi et al., <xref ref-type="bibr" rid="B168">2001</xref>; Fantegrossi et al., <xref ref-type="bibr" rid="B46">2005</xref>, <xref ref-type="bibr" rid="B47">2006</xref>; Halberstadt and Geyer, <xref ref-type="bibr" rid="B60">2014</xref>; Ceci et al., <xref ref-type="bibr" rid="B32">2015</xref>) induce head-twitches responses, while the use of monoamines modulators, induces stereotypies (Lv et al., <xref ref-type="bibr" rid="B92">2009</xref>; Taylor et al., <xref ref-type="bibr" rid="B166">2010</xref>). Stereotypic behaviors were also observed after administration of 3,3′-iminodipropionitrile (IDPN) (Wang et al., <xref ref-type="bibr" rid="B173">2013</xref>) and <italic>Catha edulis extract</italic> (Oyungu et al., <xref ref-type="bibr" rid="B113">2007</xref>).</p>
<p>The D1CT-7 transgenic mouse, originally proposed for OCD, shows head twitching and abnormal movements of limbs and trunk with juvenile onset and sexual dimorphism (Nordstrom and Burton, <xref ref-type="bibr" rid="B107">2002</xref>). These animals display PPI deficits and tic-like manifestations that are increased in presence of spatial confinement-induced. This model appears to show higher hyperactive stress reduced by antipsychotics and clonidine (Nordstrom et al., <xref ref-type="bibr" rid="B106">2015</xref>), making it the first model to show <italic>face validity</italic> for tics and feature also common TS-related phenotypes (Table <xref ref-type="table" rid="T2">2</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p><bold>Animal models of tics</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Approach</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Method</bold>
</th>
<th align="left" colspan="2" rowspan="1" valign="top">
<bold>Compound</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pharmacological</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hallucinogens (5HTR agonists)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">DOI in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Head twitch response. Reduced by donepezil (acetylcholinesterase inhibitor), nicotine (nAChR agonist) and haloperidol (DA antagonist) chronic or acute treatment</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hayslett and Tizabi, <xref ref-type="bibr" rid="B63">2003</xref>; Tizabi et al., <xref ref-type="bibr" rid="B168">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">DOI in ABH, C57BL/6N, SJL/J, and CD-1 mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Head twitch response and skin jerk responses. URB597 (FAAH inhibitor) reduced head twitch in all strains</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Ceci et al., <xref ref-type="bibr" rid="B32">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">2C-I in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Head twitch response. Blocked by M100907 (5-HTR antagonist) administration</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Halberstadt and Geyer, <xref ref-type="bibr" rid="B60">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">2C-T-7 in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Head twitch response. Antagonized by M100907 (5-HTR antagonist)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Fantegrossi et al., <xref ref-type="bibr" rid="B46">2005</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">5-MeO-DIPT in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Head twitch response. Antagonized by M100907 (5-HTR antagonist) pretreatment</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Fantegrossi et al., <xref ref-type="bibr" rid="B47">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Metamphetamine-induced hyperactive mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Motor tics and hyperactivity. Reduced by hispidulin (plant extract with antiepileptic activity) pretreatment</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Huang et al., <xref ref-type="bibr" rid="B67">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine modulators</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Apomorphine in rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Stereotyped actions. Inhibited by ningdong (biological extract) and haloperidol (DA antagonist) treatment</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Lv et al., <xref ref-type="bibr" rid="B92">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">SKF38393 in rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Super-stereotyped syntactic grooming chain. Ameliorated by haloperidol (DA antagonist)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Taylor et al., <xref ref-type="bibr" rid="B166">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Others</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">IDPN (neurotoxin) in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Stereotypies ecresaed by tiapride (DA antagonist) and by Jian-Pi-Zhi-Dong Decoction (plants extracts)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Wang et al., <xref ref-type="bibr" rid="B173">2013</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Khat cathinone (<italic>Catha edulis extract</italic>) in rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Seizures, stereotyped behaviors</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Oyungu et al., <xref ref-type="bibr" rid="B113">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal and systemic injection</td>
<td align="left" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hallucinogens in frontal cortex of wild type and B-arr2 KO mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Head twitch response</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Schmid and Bohn, <xref ref-type="bibr" rid="B143">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Focal injection</td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA antagonists</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Picrotoxin injections in DLS and SMC of mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Injections in DLS induced tic-like movement attenuated or abrogated by PMPA (NMDAR antagonist) and muscimol (GABA agonist) pretreatment; injecitons in SMC produced tic-like movements and hyperactivity abrogated by muscimol pretreatment</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Pogorelov et al., <xref ref-type="bibr" rid="B123">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">BIM injections in rat GPe</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Stereotypies, attention deficits and hyperactivity</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Grabli et al., <xref ref-type="bibr" rid="B55">2004</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">BIM injections in rat striatum</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Tic movements somatotopically organized and hyperbehavioral abnormalities</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Bronfeld et al., <xref ref-type="bibr" rid="B20">2013</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">BIM injections in primate striatum</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Periodic orofacial tics and forelimb tics, hyperactivity and stereotypic behaviors. Tics did not interfere with overall normal behavior</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">McCairn et al., <xref ref-type="bibr" rid="B100">2009</xref>; Worbe et al., <xref ref-type="bibr" rid="B180">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Genetic</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">D1CT-7 transgenic mice</td>
<td align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Seizures, tics and compulsive behaviors increased by pentylenetetrazol (convulsivant)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Campbell et al., <xref ref-type="bibr" rid="B25">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Repetitive climbing and leaping. Dizocilpine (non-competitive NMDAR antagonist) aggravated the phenotype and induced seizures; NBQX (AMPAR blocker) reduced stereotypies and seizures.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">McGrath et al., <xref ref-type="bibr" rid="B101">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="2" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tic-like movements; sensorimotor gating deficit in response to spatial confinement</td>
<td align="left" colspan="1" rowspan="1" valign="top">Godar et al., <xref ref-type="bibr" rid="B54">2015</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>List of animal models that show a motor phenotype that can be related to tic spectrum as predominant and relative drugs treatment approaches. Phenotypes are indicated as reported in literature. Abbreviations: BIM, bicuculline methiotide; DLS, dorsolateral striatum; DOI, 2,5-Dimethoxy-4-iodoamphetamine; FAAH, fatty acid amide hydrolase; IDPN, 3,3′-iminodipropionitrile; M100907, (R)-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol; NBQX, (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione); nAChR, nicotinic acetylcholine receptor; PMPA, (RS)-4-(phosphonomethyl)piperazine-2-carboxylic acid; SMC, sensorimotor cortex; URB597, fatty acid amide hydrolase; 2C-I, 2; C-I (2,5-dimethoxy]]-4-iodophenethylamine; 2C-T-7, 4-propylthio-2,5-dimethoxyphenethylamine; 5-MeO-DIPT, 5-Methoxy-diisopropyltryptamine; 5-HTR, serotonin receptor; 5-HTTP, 5-hydroxy-L-tryptophan</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Premonitory urge</title>
<p>Since pediatric age, TS patients become aware of an uncomfortable sensation that precedes tics known as premonitory urge (PU) that, for about 57% of cases, is more bothersome then tics themselves (Cohen and Leckman, <xref ref-type="bibr" rid="B36">1992</xref>; Reese et al., <xref ref-type="bibr" rid="B132">2014</xref>).</p>
<p>From a therapeutic point of view, the understanding of PU might help tic management since it could enhance the patient's own ability to suppress it (Leckman et al., <xref ref-type="bibr" rid="B86">1993</xref>; Frank and Cavanna, <xref ref-type="bibr" rid="B48">2013</xref>).</p>
<p>In adult TS patients the neurophysiological system of urge and tic generation appears to be distinct from the one implied in tic control (Ganos et al., <xref ref-type="bibr" rid="B51">2012</xref>): the urge would include both voluntary motor circuits and somatic sensation circuits (anterior cingulate cortex and supplementary motor area), while tic generation is known to take place in prefrontal structures involved in the primary inhibition of the motor control, as confirmed by neuroimaging studies (Peterson et al., <xref ref-type="bibr" rid="B120">1998</xref>).</p>
<p>The genesis of PU is still unknown but some evidence led to the hypothesis that this feeling might reflect abnormalities of sensorimotor gating, i.e., the neurological process able to filter out redundant or unnecessary environmental stimuli that constantly reach our brain (Braff et al., <xref ref-type="bibr" rid="B18">2001</xref>; Biermann-Ruben et al., <xref ref-type="bibr" rid="B15">2012</xref>).</p>
<sec>
<title>Modeling TS sensorimotor gating deficit</title>
<p>Tics are, to a certain extent, an easy-to-detect phenomenon; PU is more complicated to be translated into a preclinical model but can be investigated through the study of sensorimotor gating deficit.</p>
<p>To assess sensorimotor gating functions, the pre-pulse inhibition (PPI) of the startle response is used in both humans and laboratory animals. PPI is a behavioral phenomenon in which a weak pre-stimulus (i.e., prepulse) diminishes the reaction to a subsequent stronger stimulus (i.e., pulse) that could otherwise trigger a strong startle response. In presence of acoustic, visual or tactile stimuli, TS patients show PPI deficits manifesting the inability to filter unnecessary information (Castellanos et al., <xref ref-type="bibr" rid="B29">1996</xref>; Zebardast et al., <xref ref-type="bibr" rid="B187">2013</xref>).</p>
<p>Due to its conformity to the validity criteria, this animal model of sensorimotor gating deficits has now reasonably been extended from the single research of schizophrenia (Wan and Swerdlow, <xref ref-type="bibr" rid="B172">1996</xref>) to the study of TS and its comorbidities (Swerdlow and Sutherland, <xref ref-type="bibr" rid="B163">2005</xref>). In rodents, PPI appears to be regulated by the nucleus accumbens and its dopaminergic activation. Similar to tics, PPI abnormalities develop in rats treated with dopaminergic agonists (Alsene et al., <xref ref-type="bibr" rid="B7">2010</xref>; Mosher et al., <xref ref-type="bibr" rid="B103">2015</xref>), hallucinogens (Swerdlow et al., <xref ref-type="bibr" rid="B162">2003</xref>; Chen et al., <xref ref-type="bibr" rid="B34">2012</xref>) and glutamate antagonists (Swerdlow et al., <xref ref-type="bibr" rid="B161">2007</xref>; Pietraszek et al., <xref ref-type="bibr" rid="B122">2009</xref>). PPI deficit could also be detected in spontaneous hypertensive rats (SHR), the model of choice for ADHD (Van Den Buuse, <xref ref-type="bibr" rid="B170">2004</xref>; Table <xref ref-type="table" rid="T3">3</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p><bold>Animal models of PPI deficit: List of animal models that show a PPI deficit</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Approach</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Method</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Compound</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pharmacological</td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic administration</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Metamphetamine (5-HTR agonist), ketamine, and dizocilpine (non-competitive NMDAR antagonists) in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI deficits alleviated by <italic>Clerodendrum inerme</italic> ethanol extract treatment</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Chen et al., <xref ref-type="bibr" rid="B34">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Apomorphine (DA agonits), amphetamine (5-HTR agonist), and DOI (5-HTR agonist) in parental Sprague Dawley and Long Evans rats, and offspring</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Strain related heritable PPI changes</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Swerdlow et al., <xref ref-type="bibr" rid="B162">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Dizocilpine (non-competitive NMDAR antagonists) in rat</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Locomotor hyperactivity, PPI disruption, working memory deficit not alleviated by 1MeTIQ (NMDAR antagonistic)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Pietraszek et al., <xref ref-type="bibr" rid="B122">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Amphetamine (5-HTR agonist) in rat</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI deficit and hyperactivity. Blocked by prazosin (α1 adrenergic receptor blocker) and partially by terazosin (α1 adrenergic receptor antagonist) focal administration in nucleus accumbens</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Alsene et al., <xref ref-type="bibr" rid="B7">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Dizocilpine (non-competitive NMDAR antagonists) or apomorphine (DA agonits) in rat</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI deficit. Abolished by GTS-21 (AChR partial agonist) clozapine (5-HTR partial agonist) and haloperidol (DA antagonist)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Callahan et al., <xref ref-type="bibr" rid="B24">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">SKF82958 (DA full agonist) in Sprague-Dawley, Wistar, and Long Evans rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Strain-specific PPI deficits.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Mosher et al., <xref ref-type="bibr" rid="B103">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Focal administration</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">p-Hydroxyamphetamine (TAAR1 agonist) in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI deficit attenuated by pretreatment with 5,7-DHT (serotonin-containing neurons neurotoxin), PCPA (serotonin synthesis inhibitor), ketanserin (5-HTR antagonist), and MDL100,907 (5-HTR antagonist)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Onogi et al., <xref ref-type="bibr" rid="B111">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Granulocyte-Macrophage Colony-Stimulating Factor in rat</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hyperlocomotion; social interaction and PPI deficits. Alleviated by minocycline (antibiotic)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Zhu et al., <xref ref-type="bibr" rid="B189">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Systemic and focal administration</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Apomorphine (DA agonits) in Sprague Dawley and Long Evand rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI distrupted in Sprague-Dawley</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Swerdlow et al., <xref ref-type="bibr" rid="B161">2007</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Apomorphine (DA agonits) and amphetamine (5-HTR agonist) in rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">PPI deficit. Prevented by finasteride (5α-reductase inhibitor)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Devoto et al., <xref ref-type="bibr" rid="B45">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Genetic</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">BTBR mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Spontaneous stereotypic behavior</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Pearson et al., <xref ref-type="bibr" rid="B119">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Wistar and SHR rat</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">SHR PPI lower then Wistar rats. Reversed by WIN55212,2 (CBR agonist) and cannabidiol (CBR indirect antagonist)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Levin et al., <xref ref-type="bibr" rid="B88">2014</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">HET mice</td>
<td align="left" colspan="1" rowspan="1" valign="top">Behavioral and PPI deficits</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chohan et al., <xref ref-type="bibr" rid="B35">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Environmental</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Prolonged maternal deprivation in rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI reduction and impaired spatial learning in adulthood</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Garner et al., <xref ref-type="bibr" rid="B52">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Social isolation in rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased self-grooming and locomotor activity, PPI deficit</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Strauss et al., <xref ref-type="bibr" rid="B158">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pre- and post- weaning maternal separation and social isolation in rats</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">PPI changes in the adults following maternal separation and not social isolation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Weiss et al., <xref ref-type="bibr" rid="B175">2011</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Abbreviations: CBR, Cannabinoid receptor; DA, Dopamine; DOI, 2,5-Dimethoxy-4-iodoamphetamine; GTS-21, α7-nAChR agonists (also known as DMXB-A); HET, head tilt gene; KO, knock out; PPI, Pre Pulse Inhibition; PCPA, p-chlorophenylalanine; SHR, Spontanueous Hypertensive Rat; TAAR1, Trace amine-associated receptor 1; 1MeTIQ, 1-Methyl-1,2,3,4-tetrahydroisoquinoline; 5,7-DHT, 5,7-dihydroxytryptamine</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Environmental risk factors</title>
<p>Similar to other developmental neuropsychiatric disorders, TS perfectly fits in a so-called “multistrike model” of etiology. In this model the first hit is represented by the genetic vulnerability to the disease that is likely to be translated in structural and functional neurological changes. If these changes disturb regions with physiological self-regulatory functions -second hit- tic expression is evoked. In addition, various environmental factors (neuroendocrine, infectious, autoimmune, toxic, and psychosocial influences), representing a third strike, further increase the risk of tic expression (Spessot et al., <xref ref-type="bibr" rid="B155">2004</xref>).</p>
<p>Numerous studies have investigated environmental factors that might contribute to the onset and severity of TS and associated comorbidities. Chao et al. (<xref ref-type="bibr" rid="B33">2014</xref>) systematically reviewed studies investigating the contribution of pre- and perinatal adverse events on onset and severity of TS and its comorbidities, if present.</p>
<p>Maternal smoking appears to be consistently implicated to TS pathology (Mathews et al., <xref ref-type="bibr" rid="B98">2006</xref>; Motlagh et al., <xref ref-type="bibr" rid="B104">2010</xref>).</p>
<p>Infections, and particularly Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) were associated to worsening or causing TS (Kurlan, <xref ref-type="bibr" rid="B84">2004</xref>; Kirkman et al., <xref ref-type="bibr" rid="B78">2008</xref>; Singer et al., <xref ref-type="bibr" rid="B149">2012</xref>; Swedo et al., <xref ref-type="bibr" rid="B160">2012</xref>), however, a causal relationship between streptococcal infections and TS is still under investigation (Hoekstra and Minderaa, <xref ref-type="bibr" rid="B64">2005</xref>; Krause et al., <xref ref-type="bibr" rid="B82">2010</xref>).</p>
<p>Finally, only a few clinical studies were conducted investigating the extent to which stressors affect TS patients' life (Silva et al., <xref ref-type="bibr" rid="B147">1995</xref>) but TS patients report a strong link between stress and tics exacerbation. The hypothalamic-pituitary-adrenal axis is supported to have an enhanced responsivity in children with TS (Corbett et al., <xref ref-type="bibr" rid="B39">2008</xref>) and tic severity seems to correlate to cortisol levels (Conelea and Woods, <xref ref-type="bibr" rid="B37">2008</xref>).</p>
<sec>
<title>Modeling TS environmental risk factors</title>
<p>Several immune-mediated models have been developed according to different strategies.</p>
<p>Passive exposure to immunomediators (Ponzio et al., <xref ref-type="bibr" rid="B126">2007</xref>; Smith et al., <xref ref-type="bibr" rid="B153">2007</xref>; Depino et al., <xref ref-type="bibr" rid="B44">2011</xref>; Patel et al., <xref ref-type="bibr" rid="B116">2012</xref>; Zalcman et al., <xref ref-type="bibr" rid="B186">2012</xref>) or to immunogenic microbial components (Hoffman et al., <xref ref-type="bibr" rid="B65">2004</xref>; De Miranda et al., <xref ref-type="bibr" rid="B43">2010</xref>; Yaddanapudi et al., <xref ref-type="bibr" rid="B184">2010</xref>; Brimberg et al., <xref ref-type="bibr" rid="B19">2012</xref>; Kirsten et al., <xref ref-type="bibr" rid="B79">2012</xref>; Malkova et al., <xref ref-type="bibr" rid="B93">2012</xref>) led to increased stereotypies and locomotion. However, additional deficits in motor coordination, learning/memory and social interaction, and the presence of immune deposits in the brain severely hamper their <italic>face validity</italic> for TS (Yaddanapudi et al., <xref ref-type="bibr" rid="B184">2010</xref>).</p>
<p>Transplantation into naïve animals of antibodies derived from animals actively immunized with patients' sera (Taylor et al., <xref ref-type="bibr" rid="B167">2002</xref>; Singer et al., <xref ref-type="bibr" rid="B150">2005</xref>; Martin et al., <xref ref-type="bibr" rid="B96">2008</xref>; Zhang et al., <xref ref-type="bibr" rid="B188">2012</xref>) led to a similar phenotype and episodic vocalizations were reported (Hallett et al., <xref ref-type="bibr" rid="B62">2000</xref>).</p>
<p>The importance of stress as a factor able to exacerbate tics has for long been referred by patients. Stress paradigms have proven capable of worsening the phenotype in animal models and have been recently introduced as a way to improve their validity (Xu et al., <xref ref-type="bibr" rid="B183">2015a</xref>,<xref ref-type="bibr" rid="B182">b</xref>).</p>
<p>Stress paradigms can also be used to evaluate the ability of different stressors to predispose to abnormal behavioral development (Hall, <xref ref-type="bibr" rid="B61">1998</xref>; Pryce and Feldon, <xref ref-type="bibr" rid="B129">2003</xref>). For istance, maternal deprivation affects the social, emotional and attention domain of primates leading often to stereotypies or other dysfunctional motor activities (Márquez-Arias et al., <xref ref-type="bibr" rid="B95">2010</xref>; Rommeck et al., <xref ref-type="bibr" rid="B135">2011</xref>; Table <xref ref-type="table" rid="T4">4</xref>).</p>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p><bold>Animal model of environmental factors influencing TS</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Approach</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Method</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Compound</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Immuno-mediation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Overexpression of brain immunemediators levels</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral injection of IL-2 in rats during mid gestation</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Stereotypic behaviors and decreased conditioned eye response</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Ponzio et al., <xref ref-type="bibr" rid="B126">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral injection of IL-6 in mice during mid-gestation</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">PPI deficit</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Smith et al., <xref ref-type="bibr" rid="B153">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal injection of TGFbeta-1 in mice hippocampus</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Early: stereotypy behaviors, depression. Adult: decreased stereotypies and depression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Depino et al., <xref ref-type="bibr" rid="B44">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral injection of sIL-2R alfa/beta</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased rearing, turning, grooming, head obbing, and jumping</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Zalcman et al., <xref ref-type="bibr" rid="B186">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal injection of sIL-6R alfa</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hyper locomotor activity and stereotypic behaviors</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Patel et al., <xref ref-type="bibr" rid="B116">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Auto-antibodies injections</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal injection of IgG positive for antineuronal abs in rat striatum</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased motor stereotypies and episodic vocalizations</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hallett et al., <xref ref-type="bibr" rid="B62">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal injection of anti-strep IgM mAb in mice.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased stereotypies, head bobbing, and grooming.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Zhang et al., <xref ref-type="bibr" rid="B188">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal injection of TS sera in rat striatum</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased oral stereotypies and genital grooming</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Taylor et al., <xref ref-type="bibr" rid="B167">2002</xref>; Singer et al., <xref ref-type="bibr" rid="B150">2005</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1" style="border-bottom: thin solid #000000;"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral injection of IgG from mothers of ASD children in the first trimester of pregnancy in primates</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased stereotypies and hyperactivity</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Martin et al., <xref ref-type="bibr" rid="B96">2008</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Exposure to microbial immunogen or mimics.</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Focal injection of GAS (M6-type) homogenate in mice</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Stereotypic behavior, anxiety, and depression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Hoffman et al., <xref ref-type="bibr" rid="B65">2004</xref>; Yaddanapudi et al., <xref ref-type="bibr" rid="B184">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral injection of GAS (M18 type) cell wall components in rats</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Motor abnormalities and obsessive-compulsive behaviors. Alleviated by haloperidol (D<sub>2</sub>R antagonist) and paroxetine (SSRI), respectively</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Brimberg et al., <xref ref-type="bibr" rid="B19">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral Poly I:C injection in mice during mid gestation</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Increased grooming</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Malkova et al., <xref ref-type="bibr" rid="B93">2012</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Peripheral Poly I:C injection in mice during late gestation</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Poor early motor coordination, PPI deficit, increased locomotor activity. Behavioral deficits reversed by carprofen (COX-2 inhibitor)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">De Miranda et al., <xref ref-type="bibr" rid="B43">2010</xref></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Peripheral LPS injection in rats during mid gestation</td>
<td align="left" colspan="1" rowspan="1" valign="top">Increased repetitive behaviors in male offspring</td>
<td align="left" colspan="1" rowspan="1" valign="top">Kirsten et al., <xref ref-type="bibr" rid="B79">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stress</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Differential raising conditions in primates</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Stereotypies and SIB in nursery-raised group more than mother-raised and in the indoor raised group more then outdoor raised groups</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">Rommeck et al., <xref ref-type="bibr" rid="B135">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Environmen-tal enrichment Captive primates</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td align="left" colspan="1" rowspan="1" valign="top">Repetitive movements without paying attention to the surroundings, such as pulling one's hair, cheek pinching and swinging the body Stereotypies. Environmental enrichment reduces stereotypies, aggression and coprophilia and enhances exploration</td>
<td align="left" colspan="1" rowspan="1" valign="top">Márquez-Arias et al., <xref ref-type="bibr" rid="B95">2010</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>List of animal models in which the TS-related phenotype is reached using environmental factor modification. Abbreviations: Ab, antibody; GAS, group A streptococcus; COX, cyclooxygenase; Ig, immunoglobulin; IL, interleukine; LPS, Lipopolysaccharide; mAb, monoclonal antibody; PPI, Pre-Pulse Inhibition; SIB, self-injury behavior; SSRI, selective serotonin re-uptake inhibitors; TGF, tumor growth factor; TS, Tourette's syndrome</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec>
<title>Related psychiatric conditions</title>
<sec>
<title>ADHD</title>
<p>Attention-deficit/hyperactivity disorder (ADHD) is the most common comorbidity in TS.</p>
<p>ADHD is a neurodevelopmental disorder with an onset before age 12 (DSM-5). It affects about 5% of children, with 2–4:1 boys/girls prevalence (Polanczyk and Rohde, <xref ref-type="bibr" rid="B125">2007</xref>). The three core symptoms of ADHD are inattention, motor hyperactivity, and increased impulsivity. Inattention refers to disorganization and difficulty in sustaining focus; hyperactivity manifests as excessive motor activity or talking activeness in inappropriate situations; impulsivity refers to the tendency to perform, without adequate forethought.</p>
<p>The cause of ADHD still remains elusive but it most likely results from a combination of cofactors that can be genetic, developmental, and/or environmental. The observation that the most effective drugs for ADHD treatment are psychostimulants (Sagvolden et al., <xref ref-type="bibr" rid="B140">2005</xref>), implicates a role for catecholamines in the development of the disease. Indeed, the dopaminergic D1, D4, and D5 receptor genes, the α2-adrenoceptor gene, and both dopamine and norepinephrine transporters (DAT1, NET1) genes show polymorphisms in ADHD patients (Cook et al., <xref ref-type="bibr" rid="B38">1995</xref>; Manor et al., <xref ref-type="bibr" rid="B94">2004</xref>; Bobb et al., <xref ref-type="bibr" rid="B17">2005</xref>; Park et al., <xref ref-type="bibr" rid="B115">2005</xref>; Kickler et al., <xref ref-type="bibr" rid="B77">2009</xref>). Serotonin has also been indicated to play a role in ADHD, as suggested by polymorphisms in genes that encode the serotonin transporter and the serotonin 1B receptor (Kent et al., <xref ref-type="bibr" rid="B75">2002</xref>).</p>
<p>Since ADHD affects 60–80% of children with TS (Khalifa and Knorring, <xref ref-type="bibr" rid="B76">2007</xref>), a common pathophysiological link between these two disorders seems evident. A debate is going on whether the two pathologies are independent (additive model), combined (interactive model), or a phenotype subgroup of one of the two major clinical forms (phenotype model) (Cavanna et al., <xref ref-type="bibr" rid="B31">2009</xref>; Greimel et al., <xref ref-type="bibr" rid="B59">2011</xref>; Schlander et al., <xref ref-type="bibr" rid="B142">2011</xref>), however, there is increasing evidence for an additive model (Lebowitz et al., <xref ref-type="bibr" rid="B85">2012</xref>; Roessner et al., <xref ref-type="bibr" rid="B134">2007</xref>).</p>
<sec>
<title>Modeling ADHD</title>
<p>Inattention, motor hyperactivity, and increased impulsivity are the three core features of ADHD. They have been differently modeled using (i) genetic manipulation, for instance in DAT-KO mice, coloboma mutant mice, nicotinic receptor mutant mice, human thyroid receptor expressing mice, GAT1-KO mice, ACC mice, and mutant tachinin-1 mice (Gainetdinov and Caron, <xref ref-type="bibr" rid="B50">2000</xref>; Granon and Changeux, <xref ref-type="bibr" rid="B56">2006</xref>; Siesser et al., <xref ref-type="bibr" rid="B146">2006</xref>; Bruno et al., <xref ref-type="bibr" rid="B21">2007</xref>; Yan et al., <xref ref-type="bibr" rid="B185">2009</xref>; Zimmermann et al., <xref ref-type="bibr" rid="B191">2014</xref>), (ii) selective breeding, as in SHR rats and Naples high excitability rats (Sadile et al., <xref ref-type="bibr" rid="B138">1993</xref>; Sagvolden, <xref ref-type="bibr" rid="B139">2000</xref>) (iii) insulting events during early developmental stages through 6-hydroxydopamine lesion and prenatal nicotine exposure (Stead et al., <xref ref-type="bibr" rid="B157">2006</xref>; Schneider et al., <xref ref-type="bibr" rid="B144">2011</xref>; Zhu et al., <xref ref-type="bibr" rid="B190">2012</xref>; Freund et al., <xref ref-type="bibr" rid="B49">2014</xref>) (iv) social isolation (Ouchi et al., <xref ref-type="bibr" rid="B112">2013</xref>).</p>
<p>To validate these models, sustained attention deficits should be shown when stimuli are widely spaced in time, hyperactivity should be absent in novel situations and develop gradually over time and impulsivity should be sensitive to reinforcers (for review see Sagvolden et al., <xref ref-type="bibr" rid="B140">2005</xref>).</p>
<p>SHR rats have been the most extensively used model of ADHD and feature all core aspects of this disorders. However, in SHR rats and in all previously listed ADHD models tic-like behaviors have not been documented.</p>
<p>Animal models of TS showing comorbid full ADHD spectrum have not been reported so far, but some validity for the single features were documented: hyperactivity was associated to specific bicuculline injections sites in the dorsal striatum and dorsal GPe of primates (Grabli et al., <xref ref-type="bibr" rid="B55">2004</xref>; Worbe et al., <xref ref-type="bibr" rid="B178">2009</xref>) and attention deficit occurred after injections in associative regions of the GPe (Grabli et al., <xref ref-type="bibr" rid="B55">2004</xref>).</p>
</sec>
</sec>
<sec>
<title>OCD</title>
<p>OCD is a neuropsychiatric disease that is frequently found as comorbidity in adult TS patients. It is a chronic disorder, which affects approximately 1–3% of the population (Pallanti et al., <xref ref-type="bibr" rid="B114">2011</xref>).</p>
<p>According to DSM-5, obsessions, compulsions, or both, have to be present for an OCD diagnosis. Obsessions are defined as recurrent and persistent thoughts (e.g., fear of contamination), urges (e.g., need to wash hands), or images (e.g., of a violent or horrific scene) that are experienced as intrusive and unwanted, and cause marked anxiety and distress. The individual will try to suppress or to neutralize obsessions with some other thoughts or actions, for instance by performing a compulsion. Compulsions are defined as repetitive mental acts (e.g., counting) or behaviors (e.g., washing hands) performed in response to an obsession or according to rules that must be applied rigidly to a clearly excessive point when they become disruptive for daily living. OCD patients are able to recognize their obsessions and compulsions, but are unable to avoid them (Koran et al., <xref ref-type="bibr" rid="B81">1996</xref>; Okasha et al., <xref ref-type="bibr" rid="B110">2000</xref>).</p>
<p>The etiology of OCD is not completely understood.</p>
<p>Serotonin was the first neurotransmitter to be associated with OCD pathophysiology when selective serotonin re-uptake inhibitors (SSRIs) were shown to be efficacious in treating OCD (Barr et al., <xref ref-type="bibr" rid="B12">1992</xref>). However, many patients do not respond to SSRIs treatment suggesting the additional involvement of other NTs such as dopamine (Carey et al., <xref ref-type="bibr" rid="B26">2005</xref>; Taj et al., <xref ref-type="bibr" rid="B165">2013</xref>), GABA (Simpson et al., <xref ref-type="bibr" rid="B148">2012</xref>; Russo and Pietsch, <xref ref-type="bibr" rid="B136">2013</xref>; Russo et al., <xref ref-type="bibr" rid="B137">2014</xref>) and particularly glutamate (Arnold et al., <xref ref-type="bibr" rid="B9">2006</xref>; Alonso et al., <xref ref-type="bibr" rid="B5">2012</xref>; Porton et al., <xref ref-type="bibr" rid="B127">2013</xref>). Growing evidence indicates the latter as a putative central player in OCD pathophysiology, strengthening the glutamate hypothesis of OCD and opening a new window for the development of novel treatment strategies (Coric et al., <xref ref-type="bibr" rid="B40">2005</xref>; Grant et al., <xref ref-type="bibr" rid="B57">2007</xref>; Bakhla et al., <xref ref-type="bibr" rid="B11">2013</xref>).</p>
<p>Dopamine, GABA, and glutamate are commonly associated to CSTC circuit malfunction, implicating a role for this circuit in OCD pathophysiology (Stahl, <xref ref-type="bibr" rid="B156">1988</xref>; Insel and Winslow, <xref ref-type="bibr" rid="B70">1992</xref>; Graybiel and Rauch, <xref ref-type="bibr" rid="B58">2000</xref>; Welch et al., <xref ref-type="bibr" rid="B176">2007</xref>). Such alterations are also thought to be causative of tics, which 30% of OCD patients develop (Bloch et al., <xref ref-type="bibr" rid="B16">2006</xref>; Pallanti et al., <xref ref-type="bibr" rid="B114">2011</xref>). Tics and compulsions are now considered to be two different sides of the same coin that may be grouped under the general term of “tic-like” activities (Lombroso and Scahill, <xref ref-type="bibr" rid="B91">2008</xref>; Worbe et al., <xref ref-type="bibr" rid="B179">2010</xref>; Cath et al., <xref ref-type="bibr" rid="B30">2011</xref>; Martino et al., <xref ref-type="bibr" rid="B97">2013</xref>).</p>
<sec>
<title>Modeling OCD</title>
<p>In animal models reported to have validity for OCD the presence of obsessions has been reasonably left aside and the focus was on the presence of behavioral compulsivity, intended as the performance of repetitive, and perseverating actions and stereotypies (for review see Alonso et al., <xref ref-type="bibr" rid="B6">2015</xref>).</p>
<p>It is interesting to underline the existence of an analog to OCD in dogs: the Canine Compulsive Disorder (CCD), which leads to excessive tail chasing, light/shadow chasing, and flank sucking. These behaviors are attenuated with the same treatments used for OCD, indicating that its study may help elucidate the etiology of compulsive disorders (Ogata et al., <xref ref-type="bibr" rid="B109">2013</xref>).</p>
<p>Numerous validated approaches have been developed aiming to evaluate and quantify compulsive-like behaviors. Examples are the schedule-induced polydipsia (Woods et al., <xref ref-type="bibr" rid="B177">1993</xref>), the marble burying test (Ichimaru et al., <xref ref-type="bibr" rid="B69">1995</xref>), the signal attenuation test (Joel et al., <xref ref-type="bibr" rid="B71">2005</xref>) the nest building test (Hoffman and Rueda Morales, <xref ref-type="bibr" rid="B66">2012</xref>) and the nestlet shredding test (Angoa-Pérez et al., <xref ref-type="bibr" rid="B8">2012</xref>). These models provide the greatest ease of use and do not require any pharmacological or genetic intervention but on the other hand they do not offer any pathophysiological information.</p>
<p>Based on the clinical evidence for an involvement of serotonin in OCD, OCD-like behaviors are induced in animals by treatments with serotonergic agonists 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) (Carli et al., <xref ref-type="bibr" rid="B27">2006</xref>; Arora et al., <xref ref-type="bibr" rid="B10">2013</xref>) and m-chlorophenylpiperazine (mCPP) (Kreiss et al., <xref ref-type="bibr" rid="B83">2013</xref>), as well as with the serotonin releasing agent compound 48–80 (Wald et al., <xref ref-type="bibr" rid="B171">2009</xref>). Mice lacking TPH2, the rate-limiting enzyme of serotonin synthesis in the brain, display highly repetitive and compulsive behaviors (Kane et al., <xref ref-type="bibr" rid="B72">2012</xref>).</p>
<p>The glutamatergic hypothesis of OCD finds also a strong support in animal models. In mice lacking the AMPA receptor trafficking protein SAPAP3, glutamate signaling dysfunction is accompanied by compulsive grooming behavior (Welch et al., <xref ref-type="bibr" rid="B176">2007</xref>; Wu et al., <xref ref-type="bibr" rid="B181">2012</xref>).</p>
<p>Astrocyte-specific glutamate transporter (GLT1) inducible knockout mice exhibit OCD/TS-like behavioral spectrum, with marked increased self-injurious grooming behavior (Aida et al., <xref ref-type="bibr" rid="B2">2015</xref>). Interestigly, this is the first hint of a role for non-neuronal cells in this brain disorder. Lastly, transmembrane protein <italic>Slitrk5</italic> KO mice show OCD-like behavioral abnormalities that seem to be associated to a deficient corticostriatal neurotransmission (Abelson et al., <xref ref-type="bibr" rid="B1">2005</xref>; Shmelkov et al., <xref ref-type="bibr" rid="B145">2010</xref>). <italic>Slitrk5</italic> belongs to the same family of <italic>Slitrk1</italic>, a protein associated to TS.</p>
<p>Dopamine, that has been largely associated to TS and ADHD, is supported by animal models findings to play a role in compulsive behaviors. The treatment with the DR2 agonist quinpirole in mice marks the expression of the behavioral repertoire and long-term exposure to this drug leads to hyperactivity in A/J mice (De Haas et al., <xref ref-type="bibr" rid="B42">2012</xref>). In rats, chronic administration of the same compound causes compulsive checking (Szechtman et al., <xref ref-type="bibr" rid="B164">1998</xref>; Alkhatib et al., <xref ref-type="bibr" rid="B4">2013</xref>).</p>
<p>In the D1CT-7 transgenic mouse, the modulation of the glutamatergic cortical output on the striatal circuits obtained through the chronic potentiation of cortical and limbic D1-expressing neurons leads to the development not only of compulsive behaviors, but also of tics. This makes it the only model of comorbid tics and OCD proposed so far (Smicun et al., <xref ref-type="bibr" rid="B152">1999</xref>; Nordstrom and Burton, <xref ref-type="bibr" rid="B107">2002</xref>).</p>
</sec>
</sec>
</sec>
</sec>
<sec id="s4" sec-type="conclusions">
<title>Conclusions</title>
<p>Animal models are gaining an important role in understanding TS pathophysiology and in investigating new treatment options. In the recent years numerous models have been developed, many of which summarize more than a single aspect of the syndrome.</p>
<p>Through animal models the idea of a major role for the striatum in tics generation, already suggested by imaging and <italic>post mortem</italic> studies, was importantly strengthened. In fact, independent approaches used to model TS succeeded in showing increased grooming and tic-like phenotype following striatal structural and functional alterations. This indicates the striatum as a research target worth investing more efforts.</p>
<p>Reproducing tics, the core feature of TS, is the actual greatest challenge for animal models. A TS diagnosis requires the coexistence of multiple motor and at least a vocal tic, but so far researchers focused on motor tics while the presence and cause of vocal tics has been poorly investigated and require further attention.</p>
<p>The difference between tics and other movement disorders can be detected in humans but it is subtler in animals that physiologically account a wide range of species-specific repetitive movements in their repertoire. In patients, tics have the peculiar features of being preceded by a PU, have a waxing and waning pattern and can be voluntarily repressed. These distinctive features of tics are difficult to observe in animals and result severely biased by the approach used. Stereotypies, which are fixed, prolonged, and rhythmic repetitive behaviors with an early onset and a fixed presentation pattern (DSM-5), can be confused with tics in animal models, though they are separated clinical entities. A discriminative method between these two motor phenotypes in animal models could increase <italic>face validity</italic> and help the development of more targeted therapeutic strategies. To achieve this point, a better understanding of the animals' behavioral spectrum along with a beter knowledge of tics' generating mechanisms are needed.</p>
<p>Finally, TS is classified as a neurodevelopmental syndrome, as it is typically diagnosed in childhood or adolescence, and tics show spontaneous and substantial reduction toward the end of the second decade of life in more than half of patients. However, so far, animal model research lacked the investigation of the way development affects the phenotype. Juvenile animal models could elucidate the impact of developmental mechanisms and importantly help the study of more effective and safer therapies for young patients.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>FR and EN equally contributed to the design, drafting, writing and revising of the work. AL contributed to the design, drafting, and critical revision under a clinical point of view. BH and TB contributed to the drafting, critical revision under a pre-clinical point of view, and final approval of the work.</p>
</sec>
<sec id="s6">
<title>Funding</title>
<p>This work was supported by the European Commission Seventh Framework Programme (FP7-PEOPLE-2012-ITN), under the grant agreement n°316978.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer KRMV is a co-Topic Editor of the handling Editor for the Research Topic this article is published under. The authors and the handling Editor declared an ongoing co-authorship, and the handling Editor states that the process nevertheless met the standards of a fair and objective review.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We dedicate this work to our dear colleague and mentor AL who sadly passed away during the preparation of this manuscript.</p>
</ack>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894588/">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894588/</ext-link>.</p>
</fn>
<fn id="fn0002">
<p><sup>2</sup><ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/content/suppl/2015/01/02/1419533112.DCSupplemental">http://www.pnas.org/content/suppl/2015/01/02/1419533112.DCSupplemental</ext-link>.</p>
</fn>
<fn id="fn0003">
<p><sup>3</sup><ext-link ext-link-type="uri" xlink:href="http://www.frontiersin.org/Systems_Neuroscience/10.3389/fnsys.2013.00050/abstract">http://www.frontiersin.org/Systems_Neuroscience/10.3389/fnsys.2013.00050/abstract</ext-link>.</p>
</fn>
<fn id="fn0004">
<p><sup>4</sup><ext-link ext-link-type="uri" xlink:href="http://www.sciencedirect.com/science/article/pii/S0014488615000035">http://www.sciencedirect.com/science/article/pii/S0014488615000035</ext-link>.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abelson</surname><given-names>J. F.</given-names></name><name><surname>Kenneth</surname><given-names>K. Y.</given-names></name><name><surname>O'Roak</surname><given-names>B. J.</given-names></name><name><surname>Baek</surname><given-names>D. Y.</given-names></name><name><surname>Stillman</surname><given-names>A. A.</given-names></name><name><surname>Morgan</surname><given-names>T. M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome</article-title>. <source/>Science
<volume>310</volume>, <fpage>317</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1126/science.1116502</pub-id><pub-id pub-id-type="pmid">16224024</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aida</surname><given-names>T.</given-names></name><name><surname>Yoshida</surname><given-names>J.</given-names></name><name><surname>Nomura</surname><given-names>M.</given-names></name><name><surname>Tanimura</surname><given-names>A.</given-names></name><name><surname>Iino</surname><given-names>Y.</given-names></name><name><surname>Soma</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice</article-title>. <source/>Neuropsychopharmacology
<volume>40</volume>, <fpage>1569</fpage>–<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2015.26</pub-id><pub-id pub-id-type="pmid">25662838</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albin</surname><given-names>R. L.</given-names></name><name><surname>Mink</surname><given-names>J. W.</given-names></name></person-group> (<year>2006</year>). <article-title>Recent advances in Tourette syndrome research</article-title>. <source/>Trends Neurosci.
<volume>29</volume>, <fpage>175</fpage>–<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2006.01.001</pub-id><pub-id pub-id-type="pmid">16430974</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkhatib</surname><given-names>A. H.</given-names></name><name><surname>Dvorkin-Gheva</surname><given-names>A.</given-names></name><name><surname>Szechtman</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit</article-title>. <source/>Behav. Pharmacol.
<volume>24</volume>, <fpage>65</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1097/FBP.0b013e32835d5b7a</pub-id><pub-id pub-id-type="pmid">23249525</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>P.</given-names></name><name><surname>Gratacós</surname><given-names>M.</given-names></name><name><surname>Segalàs</surname><given-names>C.</given-names></name><name><surname>Escaramís</surname><given-names>G.</given-names></name><name><surname>Real</surname><given-names>E.</given-names></name><name><surname>Bayés</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Association between the NMDA Glutamate Receptor GRIN2B Gene and Obsessive-Compulsive Disorder</article-title>. <source/>J. Psychiatry Neurosci.
<volume>37</volume>, <fpage>273</fpage>–<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1503/jpn.110109</pub-id><pub-id pub-id-type="pmid">22433450</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alonso</surname><given-names>P.</given-names></name><name><surname>López-Solà</surname><given-names>C.</given-names></name><name><surname>Real</surname><given-names>E.</given-names></name><name><surname>Segalàs</surname><given-names>C.</given-names></name><name><surname>Menchón</surname><given-names>J. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Animal models of obsessive-compulsive disorder: utility and limitations</article-title>. <source/>Neuropsychiatr. Dis. Treat.
<volume>11</volume>, <fpage>1939</fpage>–<lpage>1955</lpage>. <pub-id pub-id-type="doi">10.2147/NDT.S62785</pub-id><pub-id pub-id-type="pmid">26346234</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alsene</surname><given-names>K. M.</given-names></name><name><surname>Fallace</surname><given-names>K.</given-names></name><name><surname>Bakshi</surname><given-names>V. P.</given-names></name></person-group> (<year>2010</year>). <article-title>Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine</article-title>. <source/>Neuropsychopharmacology
<volume>35</volume>, <fpage>2346</fpage>–<lpage>2356</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.106</pub-id><pub-id pub-id-type="pmid">20686455</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angoa-Pérez</surname><given-names>M.</given-names></name><name><surname>Kane</surname><given-names>M. J.</given-names></name><name><surname>Briggs</surname><given-names>D. I.</given-names></name><name><surname>Sykes</surname><given-names>C. E.</given-names></name><name><surname>Shah</surname><given-names>M. M.</given-names></name><name><surname>Francescutti</surname><given-names>D. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity</article-title>. <source/>J. Neurochem.
<volume>121</volume>, <fpage>974</fpage>–<lpage>984</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07739.x</pub-id><pub-id pub-id-type="pmid">22443164</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>P. D.</given-names></name><name><surname>Sicard</surname><given-names>T.</given-names></name><name><surname>Burroughs</surname><given-names>E.</given-names></name><name><surname>Richter</surname><given-names>M. A.</given-names></name><name><surname>Kennedy</surname><given-names>J. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder</article-title>. <source/>Arch. Gen. Psychiatry
<volume>63</volume>, <fpage>769</fpage>–<lpage>776</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.63.7.769</pub-id><pub-id pub-id-type="pmid">16818866</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arora</surname><given-names>T.</given-names></name><name><surname>Bhowmik</surname><given-names>M.</given-names></name><name><surname>Khanam</surname><given-names>R.</given-names></name><name><surname>Vohora</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and CREB pathway</article-title>. <source/>Behav. Brain Res.
<volume>247</volume>, <fpage>146</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2013.02.038</pub-id><pub-id pub-id-type="pmid">23473877</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakhla</surname><given-names>A. K.</given-names></name><name><surname>Verma</surname><given-names>V.</given-names></name><name><surname>Soren</surname><given-names>S.</given-names></name><name><surname>Sarkhel</surname><given-names>S.</given-names></name><name><surname>Chaudhury</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>An open-label trial of memantine in treatment-resistant obsessive-compulsive disorder</article-title>. <source/>Ind. Psychiatry J.
<volume>22</volume>, <fpage>149</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.4103/0972-6748.132930</pub-id><pub-id pub-id-type="pmid">25013317</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barr</surname><given-names>L. C.</given-names></name><name><surname>Goodman</surname><given-names>W. K.</given-names></name><name><surname>Price</surname><given-names>L. H.</given-names></name><name><surname>McDougle</surname><given-names>C. J.</given-names></name><name><surname>Charney</surname><given-names>D. S.</given-names></name></person-group> (<year>1992</year>). <article-title>The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies</article-title>. <source/>J. Clin. Psychiatry
<volume>53</volume>(<issue>Suppl.</issue>), <fpage>17</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="pmid">1532961</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berridge</surname><given-names>K. C.</given-names></name><name><surname>Aldridge</surname><given-names>J. W.</given-names></name><name><surname>Houchard</surname><given-names>K. R.</given-names></name><name><surname>Zhuang</surname><given-names>X.</given-names></name></person-group> (<year>2005</year>). <article-title>Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's</article-title>. <source/>BMC Biol.
<volume>3</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/1741-7007-3-4</pub-id><pub-id pub-id-type="pmid">15710042</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertelsen</surname><given-names>B.</given-names></name><name><surname>Stefánsson</surname><given-names>H.</given-names></name><name><surname>Rif Jensen</surname><given-names>L.</given-names></name><name><surname>Melchior</surname><given-names>L.</given-names></name><name><surname>Mol Debes</surname><given-names>N.</given-names></name><name><surname>Groth</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Association of AADAC deletion and Gilles de La Tourette Syndrome in a large European Cohort</article-title>. <source/>Biol. Psychiatry
<volume>79</volume>, <fpage>383</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.027</pub-id><pub-id pub-id-type="pmid">26444075</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biermann-Ruben</surname><given-names>K.</given-names></name><name><surname>Miller</surname><given-names>A.</given-names></name><name><surname>Franzkowiak</surname><given-names>S.</given-names></name><name><surname>Finis</surname><given-names>J.</given-names></name><name><surname>Pollok</surname><given-names>B.</given-names></name><name><surname>Wach</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Increased sensory feedback in Tourette syndrome</article-title>. <source/>Neuroimage
<volume>63</volume>, <fpage>119</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.06.059</pub-id><pub-id pub-id-type="pmid">22776453</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloch</surname><given-names>M. H.</given-names></name><name><surname>Sukhodolsky</surname><given-names>D. G.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><name><surname>Schultz</surname><given-names>R. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Fine-motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome</article-title>. <source/>J. Child Psychol. Psychiatry
<volume>47</volume>, <fpage>551</fpage>–<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2005.01561.x</pub-id><pub-id pub-id-type="pmid">16712631</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bobb</surname><given-names>A. J.</given-names></name><name><surname>Addington</surname><given-names>A. M.</given-names></name><name><surname>Sidransky</surname><given-names>E.</given-names></name><name><surname>Gornick</surname><given-names>M. C.</given-names></name><name><surname>Lerch</surname><given-names>J. P.</given-names></name><name><surname>Greenstein</surname><given-names>D. K.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Support for association between ADHD and two candidate genes: NET1 and DRD1</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>134B</volume>, <fpage>67</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30142</pub-id><pub-id pub-id-type="pmid">15717291</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Braff</surname><given-names>D. L.</given-names></name><name><surname>Geyer</surname><given-names>M. A.</given-names></name><name><surname>Swerdlow</surname><given-names>N. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies</article-title>. <source/>Psychopharmacology
<volume>156</volume>, <fpage>234</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1007/s002130100810</pub-id><pub-id pub-id-type="pmid">11549226</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimberg</surname><given-names>L.</given-names></name><name><surname>Benhar</surname><given-names>I.</given-names></name><name><surname>Mascaro-Blanco</surname><given-names>A.</given-names></name><name><surname>Alvarez</surname><given-names>K.</given-names></name><name><surname>Lotan</surname><given-names>D.</given-names></name><name><surname>Winter</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham Chorea and related neuropsychiatric disorders</article-title>. <source/>Neuropsychopharmacology
<volume>37</volume>, <fpage>2076</fpage>–<lpage>2087</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2012.56</pub-id><pub-id pub-id-type="pmid">22534626</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronfeld</surname><given-names>M.</given-names></name><name><surname>Yael</surname><given-names>D.</given-names></name><name><surname>Belelovsky</surname><given-names>K.</given-names></name><name><surname>Bar-Gad</surname><given-names>I.</given-names></name></person-group> (<year>2013</year>). <article-title>Motor tics evoked by striatal disinhibition in the rat</article-title>. <source/>Front. Syst. Neurosci.
<volume>7</volume>:<issue>50</issue>. <pub-id pub-id-type="doi">10.3389/fnsys.2013.00050</pub-id><pub-id pub-id-type="pmid">24065893</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruno</surname><given-names>K. J.</given-names></name><name><surname>Freet</surname><given-names>C. S.</given-names></name><name><surname>Twining</surname><given-names>R. C.</given-names></name><name><surname>Egami</surname><given-names>K.</given-names></name><name><surname>Grigson</surname><given-names>P. S.</given-names></name><name><surname>Hess</surname><given-names>E. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Abnormal latent inhibition and impulsivity in coloboma mice, a model of ADHD</article-title>. <source/>Neurobiol. Dis.
<volume>25</volume>, <fpage>206</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2006.09.009</pub-id><pub-id pub-id-type="pmid">17064920</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruun</surname><given-names>R. D.</given-names></name></person-group> (<year>1984</year>). <article-title>Gilles de La Tourette's syndrome. An overview of clinical experience</article-title>. <source/>J. Am. Acad. Child Psychiatry
<volume>23</volume>, <fpage>126</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1097/00004583-198403000-00002</pub-id><pub-id pub-id-type="pmid">6585414</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buse</surname><given-names>J.</given-names></name><name><surname>Schoenefeld</surname><given-names>K.</given-names></name><name><surname>Münchau</surname><given-names>A.</given-names></name><name><surname>Roessner</surname><given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Neuromodulation in Tourette syndrome: dopamine and beyond</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>37</volume>, <fpage>1069</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.10.004</pub-id><pub-id pub-id-type="pmid">23085211</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callahan</surname><given-names>P. M.</given-names></name><name><surname>Terry</surname><given-names>A. V.</given-names></name><name><surname>Tehim</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats</article-title>. <source/>Psychopharmacology
<volume>231</volume>, <fpage>3695</fpage>–<lpage>3706</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-014-3509-2</pub-id><pub-id pub-id-type="pmid">24595504</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>K. M.</given-names></name><name><surname>Veldman</surname><given-names>M. B.</given-names></name><name><surname>McGrath</surname><given-names>M. J.</given-names></name><name><surname>Burton</surname><given-names>F. H.</given-names></name></person-group> (<year>2000</year>). <article-title>TS+OCD-like neuropotentiated mice are supersensitive to seizure induction</article-title>. <source/>Neuroreport
<volume>11</volume>, <fpage>2335</fpage>–<lpage>2338</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-200007140-00053</pub-id><pub-id pub-id-type="pmid">10923696</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carey</surname><given-names>P. D.</given-names></name><name><surname>Vythilingum</surname><given-names>B.</given-names></name><name><surname>Seedat</surname><given-names>S.</given-names></name><name><surname>Muller</surname><given-names>J. E.</given-names></name><name><surname>van Ameringen</surname><given-names>M.</given-names></name><name><surname>Stein</surname><given-names>D. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]</article-title>. <source/>BMC Psychiatry
<volume>5</volume>:<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/1471-244X-5-5</pub-id><pub-id pub-id-type="pmid">15667657</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carli</surname><given-names>M.</given-names></name><name><surname>Baviera</surname><given-names>M.</given-names></name><name><surname>Invernizzi</surname><given-names>R. W.</given-names></name><name><surname>Balducci</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats</article-title>. <source/>Neuropsychopharmacology
<volume>31</volume>, <fpage>757</fpage>–<lpage>767</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1300893</pub-id><pub-id pub-id-type="pmid">16192987</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellan Baldan</surname><given-names>L.</given-names></name><name><surname>Williams</surname><given-names>K. A.</given-names></name><name><surname>Gallezot</surname><given-names>J. D.</given-names></name><name><surname>Pogorelov</surname><given-names>V.</given-names></name><name><surname>Rapanelli</surname><given-names>M.</given-names></name><name><surname>Crowley</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Histidine decarboxylase deficiency causes Tourette syndrome: parallel findings in humans and mice</article-title>. <source/>Neuron
<volume>81</volume>, <fpage>77</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.052</pub-id><pub-id pub-id-type="pmid">24411733</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellanos</surname><given-names>F. X.</given-names></name><name><surname>Fine</surname><given-names>E. J.</given-names></name><name><surname>Kaysen</surname><given-names>D.</given-names></name><name><surname>Marsh</surname><given-names>W. L.</given-names></name><name><surname>Rapoport</surname><given-names>J. L.</given-names></name><name><surname>Hallett</surname><given-names>M.</given-names></name></person-group> (<year>1996</year>). <article-title>Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results</article-title>. <source/>Biol. Psychiatry
<volume>39</volume>, <fpage>33</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/0006-3223(95)00101-8</pub-id><pub-id pub-id-type="pmid">8719124</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cath</surname><given-names>D. C.</given-names></name><name><surname>Hedderly</surname><given-names>T.</given-names></name><name><surname>Ludolph</surname><given-names>A. G.</given-names></name><name><surname>Stern</surname><given-names>J. S.</given-names></name><name><surname>Murphy</surname><given-names>T.</given-names></name><name><surname>Hartmann</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>European clinical guidelines for Tourette syndrome and other tic disorders. Part I: Assessment</article-title>. <source/>Eur. Child Adolesc. Psychiatry
<volume>20</volume>, <fpage>155</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-011-0164-6</pub-id><pub-id pub-id-type="pmid">21445723</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavanna</surname><given-names>A. E.</given-names></name><name><surname>Servo</surname><given-names>S.</given-names></name><name><surname>Monaco</surname><given-names>F.</given-names></name><name><surname>Robertson</surname><given-names>M. M.</given-names></name></person-group> (<year>2009</year>). <article-title>The behavioral spectrum of Gilles de La Tourette syndrome</article-title>. <source/>J. Neuropsychiatry Clin. Neurosci.
<volume>21</volume>, <fpage>13</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1176/jnp.2009.21.1.13</pub-id><pub-id pub-id-type="pmid">19359447</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceci</surname><given-names>C.</given-names></name><name><surname>Proietti Onori</surname><given-names>M.</given-names></name><name><surname>Macrì</surname><given-names>S.</given-names></name><name><surname>Laviola</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Interaction between the endocannabinoid and serotonergic system in the exhibition of head twitch response in four mouse strains</article-title>. <source/>Neurotox. Res.
<volume>27</volume>, <fpage>275</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-014-9510-z</pub-id><pub-id pub-id-type="pmid">25516122</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>T. K.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Pringsheim</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Prenatal risk factors for Tourette syndrome: a systematic review</article-title>. <source/>BMC Pregnancy Childbirth
<volume>14</volume>:<fpage>53</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2393-14-53</pub-id><pub-id pub-id-type="pmid">24479407</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.-L.</given-names></name><name><surname>Lee</surname><given-names>H.-J.</given-names></name><name><surname>Huang</surname><given-names>W.-J.</given-names></name><name><surname>Chou</surname><given-names>J.-F.</given-names></name><name><surname>Fan</surname><given-names>P.-C.</given-names></name><name><surname>Du</surname><given-names>J.-C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Clerodendrum inerme leaf extract alleviates animal behaviors, hyperlocomotion, and prepulse inhibition disruptions, mimicking Tourette syndrome and Schizophrenia</article-title>. <source/>Evid. Based Complement. Alternat. Med.
<volume>2012</volume>:<fpage>284301</fpage>. <pub-id pub-id-type="doi">10.1155/2012/284301</pub-id><pub-id pub-id-type="pmid">22844330</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chohan</surname><given-names>T. W.</given-names></name><name><surname>Boucher</surname><given-names>A. A.</given-names></name><name><surname>Spencer</surname><given-names>J. R.</given-names></name><name><surname>Kassem</surname><given-names>M. S.</given-names></name><name><surname>Hamdi</surname><given-names>A. A.</given-names></name><name><surname>Karl</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Partial genetic deletion of neuregulin 1 modulates the effects of stress on sensorimotor gating, dendritic morphology, and HPA axis activity in adolescent mice</article-title>. <source/>Schizophr. Bull.
<volume>40</volume>, <fpage>1272</fpage>–<lpage>1284</lpage>. <pub-id pub-id-type="doi">10.1093/schbul/sbt193</pub-id><pub-id pub-id-type="pmid">24442851</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>A. J.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>1992</year>). <article-title>Sensory phenomena associated with Gilles de La Tourette's syndrome</article-title>. <source/>J. Clin. Psychiatry
<volume>53</volume>, <fpage>319</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="pmid">1517194</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conelea</surname><given-names>C. A.</given-names></name><name><surname>Woods</surname><given-names>D. W.</given-names></name></person-group> (<year>2008</year>). <article-title>Examining the impact of distraction on tic suppression in children and adolescents with Tourette syndrome</article-title>. <source/>Behav. Res. Ther.
<volume>46</volume>, <fpage>1193</fpage>–<lpage>1200</lpage>. <pub-id pub-id-type="doi">10.1016/j.brat.2008.07.005</pub-id><pub-id pub-id-type="pmid">18774126</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>E. H.</given-names></name><name><surname>Stein</surname><given-names>M. A.</given-names></name><name><surname>Krasowski</surname><given-names>M. D.</given-names></name><name><surname>Cox</surname><given-names>N. J.</given-names></name><name><surname>Olkon</surname><given-names>D. M.</given-names></name><name><surname>Kieffer</surname><given-names>J. E.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Association of attention-deficit disorder and the dopamine transporter gene</article-title>. <source/>Am. J. Hum. Genet.
<volume>56</volume>, <fpage>993</fpage>–<lpage>998</lpage>. <pub-id pub-id-type="pmid">7717410</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbett</surname><given-names>B. A.</given-names></name><name><surname>Mendoza</surname><given-names>S. P.</given-names></name><name><surname>Baym</surname><given-names>C. L.</given-names></name><name><surname>Bunge</surname><given-names>S. A.</given-names></name><name><surname>Levine</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome</article-title>. <source/>Psychoneuroendocrinology
<volume>33</volume>, <fpage>810</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.03.014</pub-id><pub-id pub-id-type="pmid">18487023</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coric</surname><given-names>V.</given-names></name><name><surname>Taskiran</surname><given-names>S.</given-names></name><name><surname>Pittenger</surname><given-names>C.</given-names></name><name><surname>Wasylink</surname><given-names>S.</given-names></name><name><surname>Mathalon</surname><given-names>D. H.</given-names></name><name><surname>Valentine</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial</article-title>. <source/>Biol. Psychiatry
<volume>58</volume>, <fpage>424</fpage>–<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.04.043</pub-id><pub-id pub-id-type="pmid">15993857</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crane</surname><given-names>J.</given-names></name><name><surname>Fagerness</surname><given-names>J.</given-names></name><name><surname>Osiecki</surname><given-names>L.</given-names></name><name><surname>Gunnell</surname><given-names>B.</given-names></name><name><surname>Stewart</surname><given-names>S. E.</given-names></name><name><surname>Pauls</surname><given-names>D. L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Family-based genetic association study of DLGAP3 in Tourette Syndrome</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>156B</volume>, <fpage>108</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.31134</pub-id><pub-id pub-id-type="pmid">21184590</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Haas</surname><given-names>R.</given-names></name><name><surname>Seddik</surname><given-names>A.</given-names></name><name><surname>Oppelaar</surname><given-names>H.</given-names></name><name><surname>Westenberg</surname><given-names>H. G. M.</given-names></name><name><surname>Kas</surname><given-names>M. J. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Marked inbred mouse strain difference in the expression of quinpirole induced compulsive like behavior based on behavioral pattern analysis</article-title>. <source/>Eur. Neuropsychopharmacol.
<volume>22</volume>, <fpage>657</fpage>–<lpage>663</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2012.01.003</pub-id><pub-id pub-id-type="pmid">22326620</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Miranda</surname><given-names>J.</given-names></name><name><surname>Yaddanapudi</surname><given-names>K.</given-names></name><name><surname>Hornig</surname><given-names>M.</given-names></name><name><surname>Villar</surname><given-names>G.</given-names></name><name><surname>Serge</surname><given-names>R.</given-names></name><name><surname>Lipkin</surname><given-names>W. I.</given-names></name></person-group> (<year>2010</year>). <article-title>Induction of toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances</article-title>. <source/>MBio
<volume>1</volume>:<fpage>e00176</fpage>-<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1128/mbio.00176-10</pub-id><pub-id pub-id-type="pmid">20941330</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depino</surname><given-names>A. M.</given-names></name><name><surname>Lucchina</surname><given-names>L.</given-names></name><name><surname>Pitossi</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Early and adult hippocampal TGF-β1 overexpression have opposite effects on behavior</article-title>. <source/>Brain Behav. Immun.
<volume>25</volume>, <fpage>1582</fpage>–<lpage>1591</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2011.05.007</pub-id><pub-id pub-id-type="pmid">21640817</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devoto</surname><given-names>P.</given-names></name><name><surname>Frau</surname><given-names>R.</given-names></name><name><surname>Bini</surname><given-names>V.</given-names></name><name><surname>Pillolla</surname><given-names>G.</given-names></name><name><surname>Saba</surname><given-names>P.</given-names></name><name><surname>Flore</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation</article-title>. <source/>Psychoneuroendocrinology
<volume>37</volume>, <fpage>1630</fpage>–<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2011.09.018</pub-id><pub-id pub-id-type="pmid">22029952</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fantegrossi</surname><given-names>W. E.</given-names></name><name><surname>Harrington</surname><given-names>A. W.</given-names></name><name><surname>Eckler</surname><given-names>J. R.</given-names></name><name><surname>Arshad</surname><given-names>S.</given-names></name><name><surname>Rabin</surname><given-names>R. A.</given-names></name><name><surname>Winter</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Hallucinogen-like Actions of 2,5-Dimethoxy-4-(n)-Propylthiophenethylamine (2C-T-7) in mice and rats</article-title>. <source/>Psychopharmacology
<volume>181</volume>, <fpage>496</fpage>–<lpage>503</lpage>. <pub-id pub-id-type="doi">10.1007/s00213-005-0009-4</pub-id><pub-id pub-id-type="pmid">15983786</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fantegrossi</surname><given-names>W. E.</given-names></name><name><surname>Harrington</surname><given-names>A. W.</given-names></name><name><surname>Kiessel</surname><given-names>C. L.</given-names></name><name><surname>Eckler</surname><given-names>J. R.</given-names></name><name><surname>Rabin</surname><given-names>R. A.</given-names></name><name><surname>Winter</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Hallucinogen-like Actions of 5-Methoxy-N,N-Diisopropyltryptamine in mice and rats</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>83</volume>, <fpage>122</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2005.12.015</pub-id><pub-id pub-id-type="pmid">16460788</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>M.</given-names></name><name><surname>Cavanna</surname><given-names>A. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Behavioural treatments for tourette syndrome: an evidence-based review</article-title>. <source/>Behav. Neurol.
<volume>27</volume>, <fpage>105</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1155/2013/134863</pub-id><pub-id pub-id-type="pmid">23187152</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freund</surname><given-names>N.</given-names></name><name><surname>MacGillivilray</surname><given-names>H. T.</given-names></name><name><surname>Thompson</surname><given-names>B. S.</given-names></name><name><surname>Lukkes</surname><given-names>J. L.</given-names></name><name><surname>Stanis</surname><given-names>J. J.</given-names></name><name><surname>Brenhouse</surname><given-names>H. C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Sex-dependent changes in ADHD-like behaviors in juvenile rats following cortical dopamine depletion</article-title>. <source/>Behav. Brain Res.
<volume>270</volume>, <fpage>357</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.05.024</pub-id><pub-id pub-id-type="pmid">24861711</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gainetdinov</surname><given-names>R. R.</given-names></name><name><surname>Caron</surname><given-names>M. G.</given-names></name></person-group> (<year>2000</year>). <article-title>An animal model of attention deficit hyperactivity disorder</article-title>. <source/>Mol. Med. Today
<volume>6</volume>, <fpage>43</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/S1357-4310(99)01616-0</pub-id><pub-id pub-id-type="pmid">10637574</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganos</surname><given-names>C.</given-names></name><name><surname>Kahl</surname><given-names>U.</given-names></name><name><surname>Schunke</surname><given-names>O.</given-names></name><name><surname>Kühn</surname><given-names>S.</given-names></name><name><surname>Haggard</surname><given-names>P.</given-names></name><name><surname>Gerloff</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Are premonitory urges a prerequisite of tic inhibition in Gilles de La Tourette syndrome?</article-title>
<source/>J. Neurol. Neurosurg. Psychiatr.
<volume>83</volume>, <fpage>975</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2012-303033</pub-id><pub-id pub-id-type="pmid">22842713</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garner</surname><given-names>B.</given-names></name><name><surname>Wood</surname><given-names>S. J.</given-names></name><name><surname>Pantelis</surname><given-names>C.</given-names></name><name><surname>van den Buuse</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Early maternal deprivation reduces prepulse inhibition and impairs spatial learning ability in adulthood: no further effect of post-pubertal chronic corticosterone treatment</article-title>. <source/>Behav. Brain Res.
<volume>176</volume>, <fpage>323</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2006.10.020</pub-id><pub-id pub-id-type="pmid">17097157</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garner</surname><given-names>J. P.</given-names></name><name><surname>Mason</surname><given-names>G. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents</article-title>. <source/>Behav. Brain Res.
<volume>136</volume>, <fpage>83</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/S0166-4328(02)00111-0</pub-id><pub-id pub-id-type="pmid">12385793</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Godar</surname><given-names>S. C.</given-names></name><name><surname>Mosher</surname><given-names>L. J.</given-names></name><name><surname>Strathman</surname><given-names>H. J.</given-names></name><name><surname>Gochi</surname><given-names>A. M.</given-names></name><name><surname>Jones</surname><given-names>C. M.</given-names></name><name><surname>Fowler</surname><given-names>S. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement</article-title>. <source/>Br. J. Pharmacol.
<pub-id pub-id-type="doi">10.1111/bph.13243</pub-id>. [Epub ahead of print].<pub-id pub-id-type="pmid">26171666</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabli</surname><given-names>D.</given-names></name><name><surname>McCairn</surname><given-names>K.</given-names></name><name><surname>Hirsch</surname><given-names>E. C.</given-names></name><name><surname>Agid</surname><given-names>Y.</given-names></name><name><surname>Féger</surname><given-names>J.</given-names></name><name><surname>François</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study</article-title>. <source/>Brain
<volume>127(Pt 9)</volume>, <fpage>2039</fpage>–<lpage>2054</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awh220</pub-id><pub-id pub-id-type="pmid">15292053</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Granon</surname><given-names>S.</given-names></name><name><surname>Changeux</surname><given-names>J.-P.</given-names></name></person-group> (<year>2006</year>). <article-title>Attention-deficit/hyperactivity disorder: a plausible mouse model?</article-title>
<source/>Acta Paediatr.
<volume>95</volume>, <fpage>645</fpage>–<lpage>649</lpage>. <pub-id pub-id-type="doi">10.1080/08035250600719747</pub-id><pub-id pub-id-type="pmid">16754543</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>P.</given-names></name><name><surname>Lougee</surname><given-names>L.</given-names></name><name><surname>Hirschtritt</surname><given-names>M.</given-names></name><name><surname>Swedo</surname><given-names>S. E.</given-names></name></person-group> (<year>2007</year>). <article-title>An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder</article-title>. <source/>J. Child Adolesc. Psychopharmacol.
<volume>17</volume>, <fpage>761</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2007.0021</pub-id><pub-id pub-id-type="pmid">18315448</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graybiel</surname><given-names>A. M.</given-names></name><name><surname>Rauch</surname><given-names>S. L.</given-names></name></person-group> (<year>2000</year>). <article-title>Toward a neurobiology of obsessive-compulsive disorder</article-title>. <source/>Neuron
<volume>28</volume>, <fpage>343</fpage>–<lpage>347</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)00113-6</pub-id><pub-id pub-id-type="pmid">11144344</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greimel</surname><given-names>E.</given-names></name><name><surname>Schulte-Rüther</surname><given-names>M.</given-names></name><name><surname>Kamp-Becker</surname><given-names>I.</given-names></name><name><surname>Remschmidt</surname><given-names>H.</given-names></name><name><surname>Herpertz-Dahlmann</surname><given-names>B.</given-names></name><name><surname>Konrad</surname><given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Self-report and parental report of empathy in adolescents with autism</article-title>. <source/>Z. Kinder Jugendpsychiatr. Psychother.
<volume>39</volume>, <fpage>113</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1024/1422-4917/a000097</pub-id><pub-id pub-id-type="pmid">21442599</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halberstadt</surname><given-names>A. L.</given-names></name><name><surname>Geyer</surname><given-names>M. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Effects of the Hallucinogen 2,5-Dimethoxy-4-Iodophenethylamine (2C-I) and Superpotent N-Benzyl derivatives on the head twitch response</article-title>. <source/>Neuropharmacology
<volume>77</volume>, <fpage>200</fpage>–<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.08.025</pub-id><pub-id pub-id-type="pmid">24012658</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>F. S.</given-names></name></person-group> (<year>1998</year>). <article-title>Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences</article-title>. <source/>Critic. Rev. Neurobiol.
<volume>12</volume>, <fpage>129</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1615/CritRevNeurobiol.v12.i1-2.50</pub-id><pub-id pub-id-type="pmid">9444483</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallett</surname><given-names>J. J.</given-names></name><name><surname>Harling-Berg</surname><given-names>C. J.</given-names></name><name><surname>Knopf</surname><given-names>P. M.</given-names></name><name><surname>Stopa</surname><given-names>E. G.</given-names></name><name><surname>Kiessling</surname><given-names>L. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction</article-title>. <source/>J. Neuroimmunol.
<volume>111</volume>, <fpage>195</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1016/S0165-5728(00)00320-9</pub-id><pub-id pub-id-type="pmid">11063838</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayslett</surname><given-names>R. L.</given-names></name><name><surname>Tizabi</surname><given-names>Y.</given-names></name></person-group> (<year>2003</year>). <article-title>Effects of Donepezil on DOI-induced head twitch response in mice: implications for Tourette syndrome</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>76</volume>, <fpage>409</fpage>–<lpage>415</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2003.08.015</pub-id><pub-id pub-id-type="pmid">14643839</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoekstra</surname><given-names>P. J.</given-names></name><name><surname>Minderaa</surname><given-names>R. B.</given-names></name></person-group> (<year>2005</year>). <article-title>Tic disorders and obsessive-compulsive disorder: is autoimmunity involved?</article-title>
<source/>Int. Rev. Psychiatry
<volume>17</volume>, <fpage>497</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1080/02646830500382003</pub-id><pub-id pub-id-type="pmid">16401548</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>K. L.</given-names></name><name><surname>Hornig</surname><given-names>M.</given-names></name><name><surname>Yaddanapudi</surname><given-names>K.</given-names></name><name><surname>Jabado</surname><given-names>O.</given-names></name><name><surname>Lipkin</surname><given-names>W. I.</given-names></name></person-group> (<year>2004</year>). <article-title>A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>1780</fpage>–<lpage>1791</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0887-03.2004</pub-id><pub-id pub-id-type="pmid">14973249</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffman</surname><given-names>K. L.</given-names></name><name><surname>Rueda Morales</surname><given-names>R. I.</given-names></name></person-group> (<year>2012</year>). <article-title>D1 and D2 dopamine receptor antagonists decrease behavioral Bout duration, without altering the Bout's repeated behavioral components, in a naturalistic model of repetitive and compulsive behavior</article-title>. <source/>Behav. Brain Res.
<volume>230</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2012.01.041</pub-id><pub-id pub-id-type="pmid">22309982</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>W. J.</given-names></name><name><surname>Lee</surname><given-names>H. J.</given-names></name><name><surname>Chen</surname><given-names>H. L.</given-names></name><name><surname>Fan</surname><given-names>P. C.</given-names></name><name><surname>Ku</surname><given-names>Y. L.</given-names></name><name><surname>Chiou</surname><given-names>L. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Hispidulin, a constituent of clerodendrum inerme that remitted motor tics, alleviated methamphetamine-induced hyperlocomotion without motor impairment in mice</article-title>. <source/>J. Ethnopharmacol.
<volume>166</volume>, <fpage>18</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2015.03.001</pub-id><pub-id pub-id-type="pmid">25764963</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyde</surname><given-names>T. M.</given-names></name><name><surname>Aaronson</surname><given-names>B. A.</given-names></name><name><surname>Randolph</surname><given-names>C.</given-names></name><name><surname>Rickler</surname><given-names>K. C.</given-names></name><name><surname>Weinberger</surname><given-names>D. R.</given-names></name></person-group> (<year>1992</year>). <article-title>Relationship of birth weight to the phenotypic expression of Gilles de La Tourette's syndrome in monozygotic twins</article-title>. <source/>Neurology
<volume>42</volume>, <fpage>652</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.42.3.652</pub-id><pub-id pub-id-type="pmid">1549232</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichimaru</surname><given-names>Y.</given-names></name><name><surname>Egawa</surname><given-names>T.</given-names></name><name><surname>Sawa</surname><given-names>A.</given-names></name></person-group> (<year>1995</year>). <article-title>5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice</article-title>. <source/>Jpn. J. Pharmacol.
<volume>68</volume>, <fpage>65</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1254/jjp.68.65</pub-id><pub-id pub-id-type="pmid">7494384</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Insel</surname><given-names>T. R.</given-names></name><name><surname>Winslow</surname><given-names>J. T.</given-names></name></person-group> (<year>1992</year>). <article-title>Neurobiology of obsessive compulsive disorder</article-title>. <source/>Psychiatr. Clin. North Am.
<volume>15</volume>, <fpage>813</fpage>–<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1097/00004850-199206001-00008</pub-id><pub-id pub-id-type="pmid">1461798</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joel</surname><given-names>D.</given-names></name><name><surname>Doljansky</surname><given-names>J.</given-names></name><name><surname>Schiller</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>‘Compulsive’ lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex</article-title>. <source/>Eur. J. Neurosci.
<volume>21</volume>, <fpage>2252</fpage>–<lpage>2262</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04042.x</pub-id><pub-id pub-id-type="pmid">15869522</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname><given-names>M. J.</given-names></name><name><surname>Angoa-Peréz</surname><given-names>M.</given-names></name><name><surname>Briggs</surname><given-names>D. I.</given-names></name><name><surname>Sykes</surname><given-names>C. E.</given-names></name><name><surname>Francescutti</surname><given-names>D. M.</given-names></name><name><surname>Rosenberg</surname><given-names>D. R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e48975</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0048975</pub-id><pub-id pub-id-type="pmid">23139830</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>Y.</given-names></name><name><surname>Kalanithi</surname><given-names>P. S.</given-names></name><name><surname>Grantz</surname><given-names>H.</given-names></name><name><surname>Schwartz</surname><given-names>M. L.</given-names></name><name><surname>Saper</surname><given-names>C.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome</article-title>. <source/>J. Comp. Neurol.
<volume>518</volume>, <fpage>277</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22206</pub-id><pub-id pub-id-type="pmid">19941350</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Ornthanalai</surname><given-names>V. G.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Ota</surname><given-names>M.</given-names></name><name><surname>Murphy</surname><given-names>N. P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>177</fpage>–<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.97</pub-id><pub-id pub-id-type="pmid">18794888</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>L.</given-names></name><name><surname>Doerry</surname><given-names>U.</given-names></name><name><surname>Hardy</surname><given-names>E.</given-names></name><name><surname>Parmar</surname><given-names>R.</given-names></name><name><surname>Gingell</surname><given-names>K.</given-names></name><name><surname>Hawi</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Evidence that variation at the serotonin transporter gene influences susceptibility to Attention Deficit Hyperactivity Disorder (ADHD): analysis and pooled analysis</article-title>. <source/>Mol. Psychiatry
<volume>7</volume>, <fpage>908</fpage>–<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001100</pub-id><pub-id pub-id-type="pmid">12232786</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalifa</surname><given-names>N.</given-names></name><name><surname>Knorring</surname><given-names>A.-L.</given-names></name></person-group> (<year>2007</year>). <article-title>Tourette syndrome and other tic disorders in a total population of children: clinical assessment and background</article-title>. <source/>Acta Paediatr.
<volume>94</volume>, <fpage>1608</fpage>–<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1111/j.1651-2227.2005.tb01837.x</pub-id><pub-id pub-id-type="pmid">16352498</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kickler</surname><given-names>N.</given-names></name><name><surname>Lacombe</surname><given-names>E.</given-names></name><name><surname>Chassain</surname><given-names>C.</given-names></name><name><surname>Durif</surname><given-names>F.</given-names></name><name><surname>Krainik</surname><given-names>A.</given-names></name><name><surname>Farion</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Assessment of metabolic changes in the striatum of a rat model of parkinsonism: an <italic>in vivo</italic> 1 H MRS study</article-title>. <source/>NMR Biomed.
<volume>22</volume>, <fpage>207</fpage>–<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1002/nbm.1305</pub-id><pub-id pub-id-type="pmid">19130495</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirkman</surname><given-names>N. J.</given-names></name><name><surname>Libbey</surname><given-names>J. E.</given-names></name><name><surname>Sweeten</surname><given-names>T. L.</given-names></name><name><surname>Coon</surname><given-names>H. H.</given-names></name><name><surname>Miller</surname><given-names>J. N.</given-names></name><name><surname>Stevenson</surname><given-names>E. K.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>How relevant are GFAP autoantibodies in autism and Tourette syndrome?</article-title>
<source/>J. Autism Dev. Disorders
<volume>38</volume>, <fpage>333</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-007-0398-9</pub-id><pub-id pub-id-type="pmid">17578659</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirsten</surname><given-names>T. B.</given-names></name><name><surname>Chaves-Kirsten</surname><given-names>G. P.</given-names></name><name><surname>Chaible</surname><given-names>L. M.</given-names></name><name><surname>Silva</surname><given-names>A. C.</given-names></name><name><surname>Martins</surname><given-names>D. O.</given-names></name><name><surname>Britto</surname><given-names>L. R.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Hypoactivity of the central dopaminergic system and autistic-like behavior induced by a single early prenatal exposure to lipopolysaccharide</article-title>. <source/>J. Neurosci. Res.
<volume>90</volume>, <fpage>1903</fpage>–<lpage>1912</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23089</pub-id><pub-id pub-id-type="pmid">22714803</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kompoliti</surname><given-names>K.</given-names></name><name><surname>Goetz</surname><given-names>C. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome</article-title>. <source/>Mov. Disord.
<volume>13</volume>, <fpage>477</fpage>–<lpage>480</lpage>. <pub-id pub-id-type="doi">10.1002/mds.870130317</pub-id><pub-id pub-id-type="pmid">9613740</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koran</surname><given-names>L. M.</given-names></name><name><surname>Thienemann</surname><given-names>M. L.</given-names></name><name><surname>Davenport</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Quality of life for patients with obsessive-compulsive disorder</article-title>. <source/>Am. J. Psychiatry
<volume>153</volume>, <fpage>783</fpage>–<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.153.6.783</pub-id><pub-id pub-id-type="pmid">8633690</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>D.</given-names></name><name><surname>Matz</surname><given-names>J.</given-names></name><name><surname>Weidinger</surname><given-names>E.</given-names></name><name><surname>Wagner</surname><given-names>J.</given-names></name><name><surname>Wildenauer</surname><given-names>A.</given-names></name><name><surname>Obermeier</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Association between intracellular infectious agents and Tourette's syndrome</article-title>. <source/>Eur. Archiv. Psychiatry Clin. Neurosci.
<volume>260</volume>, <fpage>359</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1007/s00406-009-0084-3</pub-id><pub-id pub-id-type="pmid">19890596</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreiss</surname><given-names>D. S.</given-names></name><name><surname>Coffman</surname><given-names>C. F.</given-names></name><name><surname>Fiacco</surname><given-names>N. R.</given-names></name><name><surname>Granger</surname><given-names>J. C.</given-names></name><name><surname>Helton</surname><given-names>B. M.</given-names></name><name><surname>Jackson</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>104</volume>, <fpage>119</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2013.01.006</pub-id><pub-id pub-id-type="pmid">23333679</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurlan</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>The PANDAS hypothesis: losing its bite?</article-title>
<source/>Mov. Disord.
<volume>19</volume>, <fpage>371</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1002/mds.20107</pub-id><pub-id pub-id-type="pmid">15077234</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebowitz</surname><given-names>E. R.</given-names></name><name><surname>Motlagh</surname><given-names>M. G.</given-names></name><name><surname>Katsovich</surname><given-names>L.</given-names></name><name><surname>King</surname><given-names>R. A.</given-names></name><name><surname>Lombroso</surname><given-names>P. J.</given-names></name><name><surname>Grantz</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Tourette syndrome in youth with and without obsessive compulsive disorder and attention deficit hyperactivity disorder</article-title>. <source/>Eur. Child Adolesc. Psychiatry
<volume>21</volume>, <fpage>451</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-012-0278-5</pub-id><pub-id pub-id-type="pmid">22543961</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leckman</surname><given-names>J. F.</given-names></name><name><surname>Walker</surname><given-names>D. E.</given-names></name><name><surname>Cohen</surname><given-names>D. J.</given-names></name></person-group> (<year>1993</year>). <article-title>Premonitory urges in Tourette's syndrome</article-title>. <source/>Am. J. Psychiatry
<volume>150</volume>, <fpage>98</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.150.1.98</pub-id><pub-id pub-id-type="pmid">8417589</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennington</surname><given-names>J. B.</given-names></name><name><surname>Coppola</surname><given-names>G.</given-names></name><name><surname>Kataoka-Sasaki</surname><given-names>Y.</given-names></name><name><surname>Fernandez</surname><given-names>T. V.</given-names></name><name><surname>Palejev</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Transcriptome analysis of the human striatum in Tourette syndrome. Biol</article-title>. <source/>Psychiatry
<volume>79</volume>, <fpage>372</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.07.018</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>R.</given-names></name><name><surname>Peres</surname><given-names>F. F.</given-names></name><name><surname>Almeida</surname><given-names>V.</given-names></name><name><surname>Calzavara</surname><given-names>M. B.</given-names></name><name><surname>Zuardi</surname><given-names>A. W.</given-names></name><name><surname>Hallak</surname><given-names>J. E. C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Effects of cannabinoid drugs on the deficit of prepulse inhibition of startle in an animal model of Schizophrenia: the SHR strain</article-title>. <source/>Front. Pharmacol.
<volume>5</volume>:<issue>10</issue>. <pub-id pub-id-type="doi">10.3389/fphar.2014.00010</pub-id><pub-id pub-id-type="pmid">24567721</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Katsovich</surname><given-names>L.</given-names></name><name><surname>Ghebremichael</surname><given-names>M.</given-names></name><name><surname>Findley</surname><given-names>D. B.</given-names></name><name><surname>Grantz</surname><given-names>H.</given-names></name><name><surname>Lombroso</surname><given-names>P. J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder</article-title>. <source/>J. Child Psychol. Psychiatry
<volume>48</volume>, <fpage>157</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01687.x</pub-id><pub-id pub-id-type="pmid">17300554</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombroso</surname><given-names>P. J.</given-names></name><name><surname>Mack</surname><given-names>G.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>King</surname><given-names>R. A.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>1991</year>). <article-title>Exacerbation of Gilles de La Tourette's syndrome associated with thermal stress: a family study</article-title>. <source/>Neurology
<volume>41</volume>, <fpage>1984</fpage>–<lpage>1987</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.41.12.1984</pub-id><pub-id pub-id-type="pmid">1745360</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lombroso</surname><given-names>P. J.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Tourette syndrome and obsessive-compulsive disorder</article-title>. <source/>Brain Dev.
<volume>30</volume>, <fpage>231</fpage>–<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2007.09.001</pub-id><pub-id pub-id-type="pmid">17937978</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name></person-group> (<year>2009</year>). <article-title>Effects of Ningdong Granule on the dopamine system of Tourette's syndrome rat models</article-title>. <source/>J. Ethnopharmacol.
<volume>124</volume>, <fpage>488</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2009.05.015</pub-id><pub-id pub-id-type="pmid">19467315</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malkova</surname><given-names>N. V.</given-names></name><name><surname>Yu</surname><given-names>C. Z.</given-names></name><name><surname>Hsiao</surname><given-names>E. Y.</given-names></name><name><surname>Moore</surname><given-names>M. J.</given-names></name><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2012</year>). <article-title>Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism</article-title>. <source/>Brain Behav. Immun.
<volume>26</volume>, <fpage>607</fpage>–<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2012.01.011</pub-id><pub-id pub-id-type="pmid">22310922</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manor</surname><given-names>I.</given-names></name><name><surname>Corbex</surname><given-names>M.</given-names></name><name><surname>Eisenberg</surname><given-names>J.</given-names></name><name><surname>Gritsenkso</surname><given-names>I.</given-names></name><name><surname>Bachner-Melman</surname><given-names>R.</given-names></name><name><surname>Tyano</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Association of the dopamine D5 receptor with Attention Deficit Hyperactivity Disorder (ADHD) and scores on a continuous performance test (TOVA)</article-title>. <source/>Am. J. Med. Genet.
<volume>127B</volume>, <fpage>73</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30020</pub-id><pub-id pub-id-type="pmid">15108184</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Márquez-Arias</surname><given-names>A.</given-names></name><name><surname>Santillán-Doherty</surname><given-names>A. M.</given-names></name><name><surname>Arenas-Rosas</surname><given-names>R. V.</given-names></name><name><surname>Gasca-Matías</surname><given-names>M. P.</given-names></name><name><surname>Muñoz-Delgado</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Environmental enrichment for captive stumptail Macaques (<italic>Macaca Arctoides</italic>)</article-title>. <source/>J. Med. Primatol.
<volume>39</volume>, <fpage>32</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0684.2009.00392.x</pub-id><pub-id pub-id-type="pmid">19878431</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>L. A.</given-names></name><name><surname>Ashwood</surname><given-names>P.</given-names></name><name><surname>Braunschweig</surname><given-names>D.</given-names></name><name><surname>Cabanlit</surname><given-names>M.</given-names></name><name><surname>Van de Water</surname><given-names>J.</given-names></name><name><surname>Amaral</surname><given-names>D. G.</given-names></name></person-group> (<year>2008</year>). <article-title>Stereotypies and hyperactivity in Rhesus monkeys exposed to IgG from mothers of children with autism</article-title>. <source/>Brain Behav. Immun.
<volume>22</volume>, <fpage>806</fpage>–<lpage>816</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2007.12.007</pub-id><pub-id pub-id-type="pmid">18262386</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname><given-names>D.</given-names></name><name><surname>Macerollo</surname><given-names>A.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Neuroendocrine aspects of Tourette syndrome</article-title>. <source/>Int. Rev. Neurobiol.
<volume>112</volume>, <fpage>239</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1093/med/9780199796267.001.0001</pub-id><pub-id pub-id-type="pmid">24295624</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Bimson</surname><given-names>B.</given-names></name><name><surname>Lowe</surname><given-names>T. L.</given-names></name><name><surname>Herrera</surname><given-names>L. D.</given-names></name><name><surname>Budman</surname><given-names>C. L.</given-names></name><name><surname>Erenberg</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Association between maternal smoking and increased symptom severity in Tourette's syndrome</article-title>. <source/>Am. J. Psychiatry
<volume>163</volume>, <fpage>1066</fpage>–<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.2006.163.6.1066</pub-id><pub-id pub-id-type="pmid">16741208</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCairn</surname><given-names>K. W.</given-names></name><name><surname>Iriki</surname><given-names>A.</given-names></name><name><surname>Isoda</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Global dysrhythmia of cerebro-basal ganglia-cerebellar networks underlies motor tics following striatal disinhibition</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>697</fpage>–<lpage>708</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4018-12.2013</pub-id><pub-id pub-id-type="pmid">23303948</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCairn</surname><given-names>K. W.</given-names></name><name><surname>Bronfeld</surname><given-names>M.</given-names></name><name><surname>Belelovsky</surname><given-names>K.</given-names></name><name><surname>and</surname><given-names>Bar-Gad, I.</given-names></name></person-group> (<year>2009</year>). <article-title>The neurophysiological correlates of motor tics following focal striatal disinhibition</article-title>. <source/>Brain
<volume>132(Pt 8)</volume>, <fpage>2125</fpage>–<lpage>2138</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awp142</pub-id><pub-id pub-id-type="pmid">19506070</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrath</surname><given-names>M. J.</given-names></name><name><surname>Campbell</surname><given-names>K. M.</given-names></name><name><surname>Parks</surname><given-names>C. R.</given-names></name><name><surname>Burton</surname><given-names>F. H.</given-names></name></person-group> (<year>2000</year>). <article-title>Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder</article-title>. <source/>Brain Res.
<volume>877</volume>, <fpage>23</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(00)02646-9</pub-id><pub-id pub-id-type="pmid">10980239</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNamara</surname><given-names>R. K.</given-names></name><name><surname>Logue</surname><given-names>A.</given-names></name><name><surname>Stanford</surname><given-names>K.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Richtand</surname><given-names>N. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine</article-title>. <source/>Synapse
<volume>60</volume>, <fpage>399</fpage>–<lpage>405</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20315</pub-id><pub-id pub-id-type="pmid">16856172</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mosher</surname><given-names>L. J.</given-names></name><name><surname>Frau</surname><given-names>R.</given-names></name><name><surname>Pardu</surname><given-names>A.</given-names></name><name><surname>Pes</surname><given-names>R.</given-names></name><name><surname>Devoto</surname><given-names>P.</given-names></name><name><surname>Bortolato</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Selective activation of D1 dopamine receptors impairs sensorimotor gating in long-evans rats</article-title>. <source/>Br. J. Pharmacol. <pub-id pub-id-type="doi">10.1111/bph.13232</pub-id>. [Epub ahead of print].<pub-id pub-id-type="pmid">26101934</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motlagh</surname><given-names>M. G.</given-names></name><name><surname>Katsovich</surname><given-names>L.</given-names></name><name><surname>Thompson</surname><given-names>N.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome</article-title>. <source/>Eur. Child Adolesc. Psychiatry
<volume>19</volume>, <fpage>755</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1007/s00787-010-0115-7</pub-id><pub-id pub-id-type="pmid">20532931</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>D. A.</given-names></name></person-group> (<year>1993</year>). <article-title>Tourette's and stress</article-title>. <source/>Neurology
<volume>43</volume>, <fpage>237</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.43.1_Part_1.237-b</pub-id><pub-id pub-id-type="pmid">8423905</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordstrom</surname><given-names>E. J.</given-names></name><name><surname>Bittner</surname><given-names>K. C.</given-names></name><name><surname>McGrath</surname><given-names>M. J.</given-names></name><name><surname>Parks</surname><given-names>C. R.</given-names><suffix>III</suffix></name><name><surname>Burton</surname><given-names>F. H.</given-names></name></person-group> (<year>2015</year>). <article-title>‘Hyperglutamatergic Cortico-Striato-Thalamo-Cortical Circuit’ breaker drugs alleviate tics in a transgenic circuit model of Tourette′s syndrome</article-title>. <source/>Brain Res. <volume>1629</volume>, <fpage>38</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2015.09.032</pub-id><pub-id pub-id-type="pmid">26453289</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordstrom</surname><given-names>E. J.</given-names></name><name><surname>Burton</surname><given-names>F. H.</given-names></name></person-group> (<year>2002</year>). <article-title>A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry</article-title>. <source/>Mol. Psychiatry
<volume>7</volume>, <fpage>617</fpage>–<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001144</pub-id><pub-id pub-id-type="pmid">12140785</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeso</surname><given-names>J. A.</given-names></name><name><surname>Lanciego</surname><given-names>J. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Past, present, and future of the pathophysiological model of the Basal Ganglia</article-title>. <source/>Front. Neuroanat.
<volume>5</volume>:<issue>39</issue>. <pub-id pub-id-type="doi">10.3389/fnana.2011.00039</pub-id><pub-id pub-id-type="pmid">21808607</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>N.</given-names></name><name><surname>Gillis</surname><given-names>T. E.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Cunningham</surname><given-names>S. M.</given-names></name><name><surname>Lowen</surname><given-names>S. B.</given-names></name><name><surname>Adams</surname><given-names>B. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Brain structural abnormalities in doberman pinschers with canine compulsive disorder</article-title>. <source/>Prog. Neuro Psychopharmacol. Biol. Psychiatry
<volume>45</volume>, <fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2013.04.002</pub-id><pub-id pub-id-type="pmid">23590875</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okasha</surname><given-names>A.</given-names></name><name><surname>Lotaief</surname><given-names>F.</given-names></name><name><surname>Ashour</surname><given-names>A. M.</given-names></name><name><surname>el Mahalawy</surname><given-names>N.</given-names></name><name><surname>Seif el Dawla</surname><given-names>A.</given-names></name><name><surname>el-Kholy</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>The prevalence of obsessive compulsive symptoms in a sample of Egyptian psychiatric patients</article-title>. <source/>L'Encéphale
<volume>26</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="pmid">11064833</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Onogi</surname><given-names>H.</given-names></name><name><surname>Nakagawasai</surname><given-names>O.</given-names></name><name><surname>Sato</surname><given-names>A.</given-names></name><name><surname>Mitazaki</surname><given-names>S.</given-names></name><name><surname>Nakaya</surname><given-names>K.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>P-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission</article-title>. <source/>Behav. Brain Res.
<volume>224</volume>, <fpage>159</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2011.06.002</pub-id><pub-id pub-id-type="pmid">21689684</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ouchi</surname><given-names>H.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Murakami</surname><given-names>Y.</given-names></name><name><surname>Matsumoto</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>Social isolation induces deficit of latent learning performance in mice: a putative animal model of attention deficit/hyperactivity disorder</article-title>. <source/>Behav. Brain Res.
<volume>238</volume>, <fpage>146</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2012.10.029</pub-id><pub-id pub-id-type="pmid">23103401</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oyungu</surname><given-names>E.</given-names></name><name><surname>Kioy</surname><given-names>P. G.</given-names></name><name><surname>Patel</surname><given-names>N. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Effect of Catha Edulis (khat) on behaviour and its potential to induce seizures in Sprague Dawley rats</article-title>. <source/>East Afr. Med. J.
<volume>84</volume>, <fpage>219</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="pmid">17892196</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pallanti</surname><given-names>S.</given-names></name><name><surname>Grassi</surname><given-names>G.</given-names></name><name><surname>Sarrecchia</surname><given-names>E. D.</given-names></name><name><surname>Cantisani</surname><given-names>A.</given-names></name><name><surname>Pellegrini</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Obsessive–compulsive disorder comorbidity: clinical assessment and therapeutic implications</article-title>. <source/>Front. Psychiatry
<volume>2</volume>:<issue>70</issue>. <pub-id pub-id-type="doi">10.3389/fpsyt.2011.00070</pub-id><pub-id pub-id-type="pmid">22203806</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>L.</given-names></name><name><surname>Nigg</surname><given-names>J. T.</given-names></name><name><surname>Waldman</surname><given-names>I. D.</given-names></name><name><surname>Nummy</surname><given-names>K. A.</given-names></name><name><surname>Huang-Pollock</surname><given-names>C.</given-names></name><name><surname>Rappley</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD</article-title>. <source/>Mol. Psychiatry
<volume>10</volume>, <fpage>572</fpage>–<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001605</pub-id><pub-id pub-id-type="pmid">15520832</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Kuzhikandathil</surname><given-names>E. V.</given-names></name><name><surname>Banks</surname><given-names>W. A.</given-names></name><name><surname>Siegel</surname><given-names>A.</given-names></name><name><surname>Zalcman</surname><given-names>S. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Soluble Interleukin-6 receptor induces motor stereotypies and co-localizes with gp130 in regions linked to cortico-striato-thalamo-cortical circuits</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e41623</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0041623</pub-id><pub-id pub-id-type="pmid">22911828</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>D. L.</given-names></name></person-group> (<year>2003</year>). <article-title>An update on the genetics of Gilles de La Tourette syndrome</article-title>. <source/>J. Psychosomat. Res.
<volume>55</volume>, <fpage>7</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-3999(02)00586-X</pub-id><pub-id pub-id-type="pmid">12842226</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Raymond</surname><given-names>C. L.</given-names></name><name><surname>Stevenson</surname><given-names>J. M.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>1991</year>). <article-title>A family study of Gilles de La Tourette syndrome</article-title>. <source/>Am. J. Hum. Genet.
<volume>48</volume>, <fpage>154</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="pmid">1985456</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>B. L.</given-names></name><name><surname>Pobbe</surname><given-names>R. L.</given-names></name><name><surname>Defensor</surname><given-names>E. B.</given-names></name><name><surname>Oasay</surname><given-names>L.</given-names></name><name><surname>Bolivar</surname><given-names>V. J.</given-names></name><name><surname>Blanchard</surname><given-names>D. C.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Motor and cognitive stereotypies in the BTBR T+tf/J mouse model of autism</article-title>. <source/>Genes Brain Behav.
<volume>10</volume>, <fpage>228</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2010.00659.x</pub-id><pub-id pub-id-type="pmid">21040460</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>B. S.</given-names></name><name><surname>Skudlarski</surname><given-names>P.</given-names></name><name><surname>Anderson</surname><given-names>A. W.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Gatenby</surname><given-names>J. C.</given-names></name><name><surname>Lacadie</surname><given-names>C. M.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>A functional magnetic resonance imaging study of tic suppression in Tourette syndrome</article-title>. <source/>Archiv. Gen. Psychiatry
<volume>55</volume>, <fpage>326</fpage>–<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.55.4.326</pub-id><pub-id pub-id-type="pmid">9554428</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>B. S.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Kane</surname><given-names>M. J.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Bronen</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Basal Ganglia volumes in patients with Gilles de La Tourette syndrome</article-title>. <source/>Archiv. Gen. Psychiatry
<volume>60</volume>, <fpage>415</fpage>–<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.60.4.415</pub-id><pub-id pub-id-type="pmid">12695320</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietraszek</surname><given-names>M.</given-names></name><name><surname>Michaluk</surname><given-names>J.</given-names></name><name><surname>Romańska</surname><given-names>I.</given-names></name><name><surname>Wasik</surname><given-names>A.</given-names></name><name><surname>Gołembiowska</surname><given-names>K.</given-names></name><name><surname>Antkiewicz-Michaluk</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in rat</article-title>. <source/>Neurotoxic. Res.
<volume>16</volume>, <fpage>390</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-009-9097-y</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogorelov</surname><given-names>V.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Smith</surname><given-names>H. R.</given-names></name><name><surname>Buchanan</surname><given-names>G. F.</given-names></name><name><surname>Pittenger</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Corticostriatal interactions in the generation of tic-like behaviors after local striatal disinhibition</article-title>. <source/>Exp. Neurol. <volume>265</volume>, <fpage>122</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.01.001</pub-id><pub-id pub-id-type="pmid">25597650</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogorelov</surname><given-names>V. M.</given-names></name><name><surname>Rodriguiz</surname><given-names>R. M.</given-names></name><name><surname>Insco</surname><given-names>M. L.</given-names></name><name><surname>Caron</surname><given-names>M. G.</given-names></name><name><surname>Wetsel</surname><given-names>W. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene</article-title>. <source/>Neuropsychopharmacology
<volume>30</volume>, <fpage>1818</fpage>–<lpage>1831</lpage>. <pub-id pub-id-type="doi">10.1038/sj.npp.1300724</pub-id><pub-id pub-id-type="pmid">15856082</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polanczyk</surname><given-names>G.</given-names></name><name><surname>Rohde</surname><given-names>L. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Epidemiology of attention-deficit/hyperactivity disorder across the lifespan</article-title>. <source/>Curr. Opin. Psychiatry
<volume>20</volume>, <fpage>386</fpage>–<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1097/YCO.0b013e3281568d7a</pub-id><pub-id pub-id-type="pmid">17551354</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ponzio</surname><given-names>N. M.</given-names></name><name><surname>Servatius</surname><given-names>R.</given-names></name><name><surname>Beck</surname><given-names>K.</given-names></name><name><surname>Marzouk</surname><given-names>A.</given-names></name><name><surname>Kreider</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Cytokine levels during pregnancy influence immunological profiles and neurobehavioral patterns of the offspring</article-title>. <source/>Ann. N.Y. Acad. Sci.
<volume>1107</volume>, <fpage>118</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1381.013</pub-id><pub-id pub-id-type="pmid">17804539</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porton</surname><given-names>B.</given-names></name><name><surname>Greenberg</surname><given-names>B. D.</given-names></name><name><surname>Askland</surname><given-names>K.</given-names></name><name><surname>Serra</surname><given-names>L. M.</given-names></name><name><surname>Gesmonde</surname><given-names>J.</given-names></name><name><surname>Rudnick</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Isoforms of the Neuronal Glutamate Transporter Gene, SLC1A1/EAAC1, Negatively Modulate Glutamate Uptake: Relevance to Obsessive-Compulsive Disorder</article-title>. <source/>Transl. Psychiatry
<volume>3</volume>:<fpage>e259</fpage>. <pub-id pub-id-type="doi">10.1038/tp.2013.35</pub-id><pub-id pub-id-type="pmid">23695234</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>R. A.</given-names></name><name><surname>Kidd</surname><given-names>K. K.</given-names></name><name><surname>Cohen</surname><given-names>D. J.</given-names></name><name><surname>Pauls</surname><given-names>D. L.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name></person-group> (<year>1985</year>). <article-title>A twin study of Tourette syndrome</article-title>. <source/>Arch. Gen. Psychiatry
<volume>42</volume>, <fpage>815</fpage>–<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1985.01790310077011</pub-id><pub-id pub-id-type="pmid">3860194</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pryce</surname><given-names>C. R.</given-names></name><name><surname>Feldon</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>27</volume>, <fpage>57</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1016/S0149-7634(03)00009-5</pub-id><pub-id pub-id-type="pmid">12732223</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralph</surname><given-names>R. J.</given-names></name><name><surname>Paulus</surname><given-names>M. P.</given-names></name><name><surname>Fumagalli</surname><given-names>F.</given-names></name><name><surname>Caron</surname><given-names>M. G.</given-names></name><name><surname>Geyer</surname><given-names>M. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists</article-title>. <source/>J. Neurosci.
<volume>21</volume>, <fpage>305</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="pmid">11150348</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapanelli</surname><given-names>M.</given-names></name><name><surname>Frick</surname><given-names>L. R.</given-names></name><name><surname>Pogorelov</surname><given-names>V.</given-names></name><name><surname>Ota</surname><given-names>K. T.</given-names></name><name><surname>Abbasi</surname><given-names>E.</given-names></name><name><surname>Ohtsu</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of Tourette syndrome</article-title>. <source/>Eur. Neuropsychopharmacol.
<volume>24</volume>, <fpage>1896</fpage>–<lpage>1906</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2014.10.007</pub-id><pub-id pub-id-type="pmid">25464894</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reese</surname><given-names>H. E.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>Peterson</surname><given-names>A. L.</given-names></name><name><surname>Crowe</surname><given-names>K.</given-names></name><name><surname>Woods</surname><given-names>D. W.</given-names></name><name><surname>Piacentini</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The premonitory urge to tic: measurement, characteristics, and correlates in older adolescents and adults</article-title>. <source/>Behav. Ther.
<volume>45</volume>, <fpage>177</fpage>–<lpage>186</lpage>. <pub-id pub-id-type="doi">10.1016/j.beth.2013.09.002</pub-id><pub-id pub-id-type="pmid">24491193</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>M. M.</given-names></name><name><surname>Eapen</surname><given-names>V.</given-names></name><name><surname>Cavanna</surname><given-names>A. E.</given-names></name></person-group> (<year>2009</year>). <article-title>The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross-cultural perspective</article-title>. <source/>J. Psychosomat. Res.
<volume>67</volume>, <fpage>475</fpage>–<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychores.2009.07.010</pub-id><pub-id pub-id-type="pmid">19913651</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roessner</surname><given-names>V.</given-names></name><name><surname>Becker</surname><given-names>A.</given-names></name><name><surname>Banaschewski</surname><given-names>T.</given-names></name><name><surname>Rothenberger</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title>Psychopathological profile in children with chronic tic disorder and co-existing ADHD: additive effects</article-title>. <source/>J. Abnorm. Child Psychol.
<volume>35</volume>, <fpage>79</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1007/s10802-006-9086-z</pub-id><pub-id pub-id-type="pmid">17171537</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rommeck</surname><given-names>I.</given-names></name><name><surname>Capitanio</surname><given-names>J. P.</given-names></name><name><surname>Strand</surname><given-names>S. C.</given-names></name><name><surname>McCowan</surname><given-names>B.</given-names></name></person-group> (<year>2011</year>). <article-title>Early social experience affects behavioral and physiological responsiveness to stressful conditions in infant Rhesus Macaques (<italic>Macaca Mulatta</italic>)</article-title>. <source/>Am. J. Primatol.
<volume>73</volume>, <fpage>692</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1002/ajp.20953</pub-id><pub-id pub-id-type="pmid">21462233</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>A. J.</given-names></name><name><surname>Pietsch</surname><given-names>S. C.</given-names></name></person-group> (<year>2013</year>). <article-title>Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in individuals with Obsessive-Compulsive Disorder (OCD)</article-title>. <source/>Biomarker Insights
<volume>8</volume>, <fpage>107</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.4137/BMI.S11931</pub-id><pub-id pub-id-type="pmid">24023510</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russo</surname><given-names>M.</given-names></name><name><surname>Naro</surname><given-names>A.</given-names></name><name><surname>Mastroeni</surname><given-names>C.</given-names></name><name><surname>Morgante</surname><given-names>F.</given-names></name><name><surname>Terranova</surname><given-names>C.</given-names></name><name><surname>Muscatello</surname><given-names>M. R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Obsessive-compulsive disorder: a ‘Sensory-Motor’ problem?</article-title>
<source/>Int. J. Psychophysiol.
<volume>92</volume>, <fpage>74</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijpsycho.2014.02.007</pub-id><pub-id pub-id-type="pmid">24631627</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadile</surname><given-names>A. G.</given-names></name><name><surname>Lamberti</surname><given-names>C.</given-names></name><name><surname>Siegfried</surname><given-names>B.</given-names></name><name><surname>Welzl</surname><given-names>H.</given-names></name></person-group> (<year>1993</year>). <article-title>Circadian activity, nociceptive thresholds, nigrostriatal and mesolimbic dopaminergic activity in the Naples High- and Low-Excitability rat lines</article-title>. <source/>Behav. Brain Res.
<volume>55</volume>, <fpage>17</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/0166-4328(93)90003-9</pub-id><pub-id pub-id-type="pmid">8101085</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagvolden</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>Behavioral validation of the spontaneously hypertensive rat (SHR) as an animal model of attention-deficit/hyperactivity disorder (AD/HD)</article-title>. <source/>Neurosci. Biobehav. Rev.
<volume>24</volume>, <fpage>31</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/S0149-7634(99)00058-5</pub-id><pub-id pub-id-type="pmid">10654658</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sagvolden</surname><given-names>T.</given-names></name><name><surname>Russell</surname><given-names>V. A.</given-names></name><name><surname>Aase</surname><given-names>H.</given-names></name><name><surname>Johansen</surname><given-names>E. B.</given-names></name><name><surname>Farshbaf</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>Rodent models of attention-deficit/hyperactivity disorder</article-title>. <source/>Biol. Psychiatry
<volume>57</volume>, <fpage>1239</fpage>–<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.02.002</pub-id><pub-id pub-id-type="pmid">15949994</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>J. M.</given-names></name><name><surname>Yu</surname><given-names>D.</given-names></name><name><surname>Mathews</surname><given-names>C. A.</given-names></name><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Stewart</surname><given-names>S. E.</given-names></name><name><surname>Fagerness</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Genome-wide association study of Tourette's syndrome</article-title>. <source/>Mol. Psychiatry
<volume>18</volume>, <fpage>721</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2012.69</pub-id><pub-id pub-id-type="pmid">22889924</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlander</surname><given-names>M.</given-names></name><name><surname>Schwarz</surname><given-names>O.</given-names></name><name><surname>Rothenberger</surname><given-names>A.</given-names></name><name><surname>Roessner</surname><given-names>V.</given-names></name></person-group> (<year>2011</year>). <article-title>Tic disorders: administrative prevalence and co-occurrence with attention-deficit/hyperactivity disorder in a German community sample</article-title>. <source/>Eur. Psychiatry
<volume>26</volume>, <fpage>370</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpsy.2009.10.003</pub-id><pub-id pub-id-type="pmid">20427154</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>C. L.</given-names></name><name><surname>Bohn</surname><given-names>L. M.</given-names></name></person-group> (<year>2010</year>). <article-title>Serotonin, but Not N-Methyltryptamines, Activates the Serotonin 2A Receptor via a ß-arrestin2/Src/Akt signaling complex <italic>in vivo</italic></article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>13513</fpage>–<lpage>13524</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1665-10.2010</pub-id><pub-id pub-id-type="pmid">20926677</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>T.</given-names></name><name><surname>Ilott</surname><given-names>N.</given-names></name><name><surname>Brolese</surname><given-names>G.</given-names></name><name><surname>Bizarro</surname><given-names>L.</given-names></name><name><surname>Asherson</surname><given-names>P. J.</given-names></name><name><surname>Stolerman</surname><given-names>I. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats</article-title>. <source/>Neuropsychopharmacology
<volume>36</volume>, <fpage>1114</fpage>–<lpage>1125</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2010.249</pub-id><pub-id pub-id-type="pmid">21289608</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shmelkov</surname><given-names>S. V.</given-names></name><name><surname>Hormigo</surname><given-names>A.</given-names></name><name><surname>Jing</surname><given-names>D.</given-names></name><name><surname>Proenca</surname><given-names>C. C.</given-names></name><name><surname>Bath</surname><given-names>K. G.</given-names></name><name><surname>Milde</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice</article-title>. <source/>Nat. Med.
<volume>16</volume>, <fpage>598</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1038/nm.2125</pub-id><pub-id pub-id-type="pmid">20418887</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siesser</surname><given-names>W. B.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Miller</surname><given-names>L. R.</given-names></name><name><surname>Cheng</surname><given-names>S. Y.</given-names></name><name><surname>McDonald</surname><given-names>M. P.</given-names></name></person-group> (<year>2006</year>). <article-title>Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive</article-title>. <source/>Genes Brain Behav.
<volume>5</volume>, <fpage>282</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2005.00161.x</pub-id><pub-id pub-id-type="pmid">16594981</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>R. R.</given-names></name><name><surname>Munoz</surname><given-names>D. M.</given-names></name><name><surname>Barickman</surname><given-names>J.</given-names></name><name><surname>Friedhoff</surname><given-names>A. J.</given-names></name></person-group> (<year>1995</year>). <article-title>Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder</article-title>. <source/>J. Child Psychol. Psychiatry
<volume>36</volume>, <fpage>305</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7610.1995.tb01826.x</pub-id><pub-id pub-id-type="pmid">7759592</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>H. B.</given-names></name><name><surname>Shungu</surname><given-names>D. C.</given-names></name><name><surname>Bender</surname><given-names>J.</given-names><suffix>Jr.</suffix></name><name><surname>Mao</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Slifstein</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy</article-title>. <source/>Neuropsychopharmacology
<volume>37</volume>, <fpage>2684</fpage>–<lpage>2692</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2012.132</pub-id><pub-id pub-id-type="pmid">22850733</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>H. S.</given-names></name><name><surname>Gilbert</surname><given-names>D. L.</given-names></name><name><surname>Wolf</surname><given-names>D. S.</given-names></name><name><surname>Mink</surname><given-names>J. W.</given-names></name><name><surname>Kurlan</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Moving from PANDAS to CANS</article-title>. <source/>J. Pediatrics
<volume>160</volume>, <fpage>725</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2011.11.040</pub-id><pub-id pub-id-type="pmid">22197466</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>H. S.</given-names></name><name><surname>Mink</surname><given-names>J. W.</given-names></name><name><surname>Loiselle</surname><given-names>C. R.</given-names></name><name><surname>Burke</surname><given-names>K. A.</given-names></name><name><surname>Ruchkina</surname><given-names>I.</given-names></name><name><surname>Morshed</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Microinfusion of antineuronal antibodies into rodent striatum: failure to differentiate between elevated and low titers</article-title>. <source/>J. Neuroimmunol.
<volume>163</volume>, <fpage>8</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2005.02.018</pub-id><pub-id pub-id-type="pmid">15885303</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>H. S.</given-names></name><name><surname>Reiss</surname><given-names>A. L.</given-names></name><name><surname>Brown</surname><given-names>J. E.</given-names></name><name><surname>Aylward</surname><given-names>E. H.</given-names></name><name><surname>Shih</surname><given-names>B.</given-names></name><name><surname>Chee</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>Volumetric MRI changes in Basal Ganglia of children with Tourette's syndrome</article-title>. <source/>Neurology
<volume>43</volume>, <fpage>950</fpage>–<lpage>956</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.43.5.950</pub-id><pub-id pub-id-type="pmid">8492951</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smicun</surname><given-names>Y.</given-names></name><name><surname>Campbell</surname><given-names>S. D.</given-names></name><name><surname>Chen</surname><given-names>M. A.</given-names></name><name><surname>Gu</surname><given-names>H.</given-names></name><name><surname>Rudnick</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>). <article-title>The role of external loop regions in serotonin transport. Loop scanning mutagenesis of the serotonin transporter external domain</article-title>. <source/>J. Biol. Chem.
<volume>274</volume>, <fpage>36058</fpage>–<lpage>36064</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.51.36058</pub-id><pub-id pub-id-type="pmid">10593887</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>S. E.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Garbett</surname><given-names>K.</given-names></name><name><surname>Mirnics</surname><given-names>K.</given-names></name><name><surname>Patterson</surname><given-names>P. H.</given-names></name></person-group> (<year>2007</year>). <article-title>Maternal immune activation alters fetal brain development through interleukin-6</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>10695</fpage>–<lpage>10702</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2178-07.2007</pub-id><pub-id pub-id-type="pmid">17913903</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sowell</surname><given-names>E. R.</given-names></name><name><surname>Kan</surname><given-names>E.</given-names></name><name><surname>Yoshii</surname><given-names>J.</given-names></name><name><surname>Thompson</surname><given-names>P. M.</given-names></name><name><surname>Bansal</surname><given-names>R.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Thinning of sensorimotor cortices in children with Tourette syndrome</article-title>. <source/>Nat. Neurosci.
<volume>11</volume>, <fpage>637</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2121</pub-id><pub-id pub-id-type="pmid">18488025</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spessot</surname><given-names>A. L.</given-names></name><name><surname>Plessen</surname><given-names>K. J.</given-names></name><name><surname>Peterson</surname><given-names>B. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuroimaging of developmental psychopathologies: the importance of self-regulatory and neuroplastic processes in adolescence</article-title>. <source/>Ann. N.Y. Acad. Sci.
<volume>1021</volume>, <fpage>86</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1308.010</pub-id><pub-id pub-id-type="pmid">15251878</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stahl</surname><given-names>S. M.</given-names></name></person-group> (<year>1988</year>). <article-title>Basal Ganglia neuropharmacology and obsessive-compulsive disorder: the obsessive-compulsive disorder hypothesis of Basal Ganglia dysfunction</article-title>. <source/>Psychopharmacol. Bull.
<volume>24</volume>, <fpage>370</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="pmid">3153495</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stead</surname><given-names>J. D.</given-names></name><name><surname>Clinton</surname><given-names>S.</given-names></name><name><surname>Neal</surname><given-names>C.</given-names></name><name><surname>Schneider</surname><given-names>J.</given-names></name><name><surname>Jama</surname><given-names>A.</given-names></name><name><surname>Miller</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Selective breeding for divergence in novelty-seeking traits: heritability and enrichment in spontaneous anxiety-related behaviors</article-title>. <source/>Behav. Genet. <volume>36</volume>, <fpage>697</fpage>–<lpage>712</lpage>. <pub-id pub-id-type="doi">10.1007/s10519-006-9058-7</pub-id><pub-id pub-id-type="pmid">16502134</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>L.</given-names></name><name><surname>Brink</surname><given-names>C. B.</given-names></name><name><surname>Möller</surname><given-names>M.</given-names></name><name><surname>Stein</surname><given-names>D. J.</given-names></name><name><surname>Harvey</surname><given-names>B. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Late-life effects of chronic methamphetamine exposure during puberty on behaviour and corticostriatal mono-amines in social isolation-reared rats</article-title>. <source/>Dev. Neurosci.
<volume>36</volume>, <fpage>18</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1159/000357495</pub-id><pub-id pub-id-type="pmid">24481048</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundaram</surname><given-names>S. K.</given-names></name><name><surname>Huq</surname><given-names>A. M.</given-names></name><name><surname>Wilson</surname><given-names>B. J.</given-names></name><name><surname>Chugani</surname><given-names>H. T.</given-names></name></person-group> (<year>2010</year>). <article-title>Tourette syndrome is associated with recurrent exonic copy number variants</article-title>. <source/>Neurology
<volume>74</volume>, <fpage>1583</fpage>–<lpage>1590</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181e0f147</pub-id><pub-id pub-id-type="pmid">20427753</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swedo</surname><given-names>S. E.</given-names></name><name><surname>Baird</surname><given-names>G.</given-names></name><name><surname>Cook</surname><given-names>E. H.</given-names><suffix>Jr.</suffix></name><name><surname>Happé</surname><given-names>F. G.</given-names></name><name><surname>Harris</surname><given-names>J. C.</given-names></name><name><surname>Kaufmann</surname><given-names>W. E.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Commentary from the DSM-5 workgroup on neurodevelopmental disorders</article-title>. <source/>J. Am. Acad. Child Adolesc. Psychiatry
<volume>51</volume>, <fpage>347</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaac.2012.02.013</pub-id><pub-id pub-id-type="pmid">22449639</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>N. R.</given-names></name><name><surname>Shoemaker</surname><given-names>J. M.</given-names></name><name><surname>Bongiovanni</surname><given-names>M. J.</given-names></name><name><surname>Neary</surname><given-names>A. C.</given-names></name><name><surname>Tochen</surname><given-names>L. S.</given-names></name><name><surname>Saint Marie</surname><given-names>R. L.</given-names></name></person-group> (<year>2007</year>). <article-title>Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>87</volume>, <fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2007.03.014</pub-id><pub-id pub-id-type="pmid">17475315</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>N. R.</given-names></name><name><surname>Shoemaker</surname><given-names>J. M.</given-names></name><name><surname>Platten</surname><given-names>A.</given-names></name><name><surname>Pitcher</surname><given-names>L.</given-names></name><name><surname>Goins</surname><given-names>J.</given-names></name><name><surname>Crain</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>75</volume>, <fpage>191</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/S0091-3057(03)00078-9</pub-id><pub-id pub-id-type="pmid">12759127</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swerdlow</surname><given-names>N. R.</given-names></name><name><surname>Sutherland</surname><given-names>A. N.</given-names></name></person-group> (<year>2005</year>). <article-title>Using animal models to develop therapeutics for Tourette syndrome</article-title>. <source/>Pharmacol. Ther.
<volume>108</volume>, <fpage>281</fpage>–<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.05.003</pub-id><pub-id pub-id-type="pmid">15970330</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szechtman</surname><given-names>H.</given-names></name><name><surname>Sulis</surname><given-names>W.</given-names></name><name><surname>Eilam</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>). <article-title>Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD)</article-title>. <source/>Behav. Neurosci.
<volume>112</volume>, <fpage>1475</fpage>–<lpage>1485</lpage>. <pub-id pub-id-type="pmid">9926830</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taj</surname><given-names>M. J. R. J.</given-names></name><name><surname>Viswanath</surname><given-names>B.</given-names></name><name><surname>Purushottam</surname><given-names>M.</given-names></name><name><surname>Kandavel</surname><given-names>T.</given-names></name><name><surname>Janardhan Reddy</surname><given-names>Y. C.</given-names></name><name><surname>Jain</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>DRD4 gene and obsessive compulsive disorder: do symptom dimensions have specific genetic correlates?</article-title>
<source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
<volume>41</volume>, <fpage>18</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2012.10.023</pub-id><pub-id pub-id-type="pmid">23127570</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>J. L.</given-names></name><name><surname>Rajbhandari</surname><given-names>A. K.</given-names></name><name><surname>Berridge</surname><given-names>K. C.</given-names></name><name><surname>Aldridge</surname><given-names>J. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome</article-title>. <source/>Brain Res.
<volume>1322</volume>, <fpage>92</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.01.052</pub-id><pub-id pub-id-type="pmid">20114036</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>J. R.</given-names></name><name><surname>Morshed</surname><given-names>S. A.</given-names></name><name><surname>Parveen</surname><given-names>S.</given-names></name><name><surname>Mercadante</surname><given-names>M. T.</given-names></name><name><surname>Scahill</surname><given-names>L.</given-names></name><name><surname>Peterson</surname><given-names>B. S.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>An animal model of Tourette's syndrome</article-title>. <source/>Am. J. Psychiatry
<volume>159</volume>, <fpage>657</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.159.4.657</pub-id><pub-id pub-id-type="pmid">11925307</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tizabi</surname><given-names>Y.</given-names></name><name><surname>Russell</surname><given-names>L. T.</given-names></name><name><surname>Johnson</surname><given-names>M.</given-names></name><name><surname>Darmani</surname><given-names>N. A.</given-names></name></person-group> (<year>2001</year>). <article-title>Nicotine attenuates DOI-induced head-twitch response in mice: implications for Tourette syndrome</article-title>. <source/>Prog. Neuro-Psychopharmacol. Biol. Psychiatry
<volume>25</volume>, <fpage>1445</fpage>–<lpage>1457</lpage>. <pub-id pub-id-type="doi">10.1016/S0278-5846(01)00194-4</pub-id><pub-id pub-id-type="pmid">11513358</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Udvardi</surname><given-names>P. T.</given-names></name><name><surname>Nespoli</surname><given-names>E.</given-names></name><name><surname>Rizzo</surname><given-names>F.</given-names></name><name><surname>Hengerer</surname><given-names>B.</given-names></name><name><surname>Ludolph</surname><given-names>A. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome</article-title>. <source/>Int. Rev. Neurobiol.
<volume>112</volume>, <fpage>95</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-411546-0.00004-4</pub-id><pub-id pub-id-type="pmid">24295619</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Den Buuse</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Prepulse inhibition of acoustic startle in spontaneously hypertensive rats</article-title>. <source/>Behav. Brain Res.
<volume>154</volume>, <fpage>331</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2004.02.021</pub-id><pub-id pub-id-type="pmid">15313020</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>R.</given-names></name><name><surname>Dodman</surname><given-names>N.</given-names></name><name><surname>Shuster</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder</article-title>. <source/>Exp. Clin. Psychopharmacol.
<volume>17</volume>, <fpage>191</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1037/a0016402</pub-id><pub-id pub-id-type="pmid">19586234</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>F. J.</given-names></name><name><surname>Swerdlow</surname><given-names>N. R.</given-names></name></person-group> (<year>1996</year>). <article-title>Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions</article-title>. <source/>Brain Research
<volume>722</volume>, <fpage>168</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(96)00209-0</pub-id><pub-id pub-id-type="pmid">8813362</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D. H.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>X. F.</given-names></name><name><surname>Zhang</surname><given-names>J. M.</given-names></name><name><surname>Wang</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Chinese medicine formula ‘Jian-Pi-Zhi-Dong Decoction’ attenuates Tourette syndrome via downregulating the expression of dopamine transporter in mice</article-title>. <source/>Evid. Based Complement. Alternat. Med.
<volume>2013</volume>:<fpage>385685</fpage>
<pub-id pub-id-type="doi">10.1155/2013/385685</pub-id><pub-id pub-id-type="pmid">23431337</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Maia</surname><given-names>T. V.</given-names></name><name><surname>Marsh</surname><given-names>R.</given-names></name><name><surname>Colibazzi</surname><given-names>T.</given-names></name><name><surname>Gerber</surname><given-names>A.</given-names></name><name><surname>Peterson</surname><given-names>B. S.</given-names></name></person-group> (<year>2011</year>). <article-title>The neural circuits that generate tics in Tourette's syndrome</article-title>. <source/>Am. J. Psychiatry
<volume>168</volume>, <fpage>1326</fpage>–<lpage>1337</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2011.09111692</pub-id><pub-id pub-id-type="pmid">21955933</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>I. C.</given-names></name><name><surname>Franklin</surname><given-names>T. B.</given-names></name><name><surname>Vizi</surname><given-names>S.</given-names></name><name><surname>Mansuy</surname><given-names>I. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Inheritable effect of unpredictable maternal separation on behavioral responses in mice</article-title>. <source/>Front. Behav. Neurosci.
<volume>5</volume>:<issue>3</issue>. <pub-id pub-id-type="doi">10.3389/fnbeh.2011.00003</pub-id><pub-id pub-id-type="pmid">21331159</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>J. M.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Rodriguiz</surname><given-names>R. M.</given-names></name><name><surname>Trotta</surname><given-names>N. C.</given-names></name><name><surname>Peca</surname><given-names>J.</given-names></name><name><surname>Ding</surname><given-names>J. D.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice</article-title>. <source/>Nature
<volume>448</volume>, <fpage>894</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1038/nature06104</pub-id><pub-id pub-id-type="pmid">17713528</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>A.</given-names></name><name><surname>Smith</surname><given-names>C.</given-names></name><name><surname>Szewczak</surname><given-names>M.</given-names></name><name><surname>Dunn</surname><given-names>R. W.</given-names></name><name><surname>Cornfeldt</surname><given-names>M.</given-names></name><name><surname>Corbett</surname><given-names>R.</given-names></name></person-group> (<year>1993</year>). <article-title>Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder</article-title>. <source/>Psychopharmacology
<volume>112</volume>, <fpage>195</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1007/BF02244910</pub-id><pub-id pub-id-type="pmid">7871019</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worbe</surname><given-names>Y.</given-names></name><name><surname>Baup</surname><given-names>N.</given-names></name><name><surname>Grabli</surname><given-names>D.</given-names></name><name><surname>Chaigneau</surname><given-names>M.</given-names></name><name><surname>Mounayar</surname><given-names>S.</given-names></name><name><surname>McCairn</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Behavioral and movement disorders induced by local inhibitory dysfunction in primate striatum</article-title>. <source/>Cereb. Cortex
<volume>19</volume>, <fpage>1844</fpage>–<lpage>1856</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bhn214</pub-id><pub-id pub-id-type="pmid">19068490</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worbe</surname><given-names>Y.</given-names></name><name><surname>Mallet</surname><given-names>L.</given-names></name><name><surname>Golmard</surname><given-names>J. L.</given-names></name><name><surname>Béhar</surname><given-names>C.</given-names></name><name><surname>Durif</surname><given-names>F.</given-names></name><name><surname>Jalenques</surname><given-names>I.</given-names></name><name><surname>Damier</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Repetitive behaviours in patients with Gilles de La Tourette syndrome: tics, compulsions, or both?</article-title>
<source/>PLoS ONE
<volume>5</volume>:<fpage>e12959</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0012959</pub-id><pub-id pub-id-type="pmid">20885982</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Worbe</surname><given-names>Y.</given-names></name><name><surname>Sgambato-Faure</surname><given-names>V.</given-names></name><name><surname>Epinat</surname><given-names>J.</given-names></name><name><surname>Chaigneau</surname><given-names>M.</given-names></name><name><surname>Tandé</surname><given-names>D.</given-names></name><name><surname>François</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Towards a primate model of Gilles de La tourette syndrome: anatomo-behavioural correlation of disorders induced by striatal dysfunction</article-title>. <source/>Cortex
<volume>49</volume>, <fpage>1126</fpage>–<lpage>1140</lpage>. <pub-id pub-id-type="doi">10.1016/j.cortex.2012.08.020</pub-id><pub-id pub-id-type="pmid">23040317</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Hanna</surname><given-names>G. L.</given-names></name><name><surname>Rosenberg</surname><given-names>D. R.</given-names></name><name><surname>Arnold</surname><given-names>P. D.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>100</volume>, <fpage>726</fpage>–<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2011.10.007</pub-id><pub-id pub-id-type="pmid">22024159</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Kobets</surname><given-names>A.</given-names></name><name><surname>Du</surname><given-names>J. C.</given-names></name><name><surname>Lennington</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Banasr</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015b</year>). <article-title>Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>112</volume>, <fpage>893</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1419533112</pub-id><pub-id pub-id-type="pmid">25561540</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Ohtsu</surname><given-names>H.</given-names></name><name><surname>Pittenger</surname><given-names>C.</given-names></name></person-group> (<year>2015a</year>). <article-title>Histidine decarboxylase knockout mice, a genetic model of tourette syndrome, show repetitive grooming after induced fear</article-title>. <source/>Neurosci. Lett.
<volume>595</volume>, <fpage>50</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2015.03.067</pub-id><pub-id pub-id-type="pmid">25841792</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaddanapudi</surname><given-names>K.</given-names></name><name><surname>Hornig</surname><given-names>M.</given-names></name><name><surname>Serge</surname><given-names>R.</given-names></name><name><surname>De Miranda</surname><given-names>J.</given-names></name><name><surname>Baghban</surname><given-names>A.</given-names></name><name><surname>Villar</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection</article-title>. <source/>Mol. Psychiatry
<volume>15</volume>, <fpage>712</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.77</pub-id><pub-id pub-id-type="pmid">19668249</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>T. C.</given-names></name><name><surname>Hunt</surname><given-names>S. P.</given-names></name><name><surname>Stanford</surname><given-names>S. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Behavioural and neurochemical abnormalities in mice lacking functional tachykinin-1 (NK1) receptors: a model of attention deficit hyperactivity disorder</article-title>. <source/>Neuropharmacology
<volume>57</volume>, <fpage>627</fpage>–<lpage>635</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2009.08.021</pub-id><pub-id pub-id-type="pmid">19748515</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalcman</surname><given-names>S. S.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Mohla</surname><given-names>R.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Siegel</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Soluble cytokine receptors (sIL-2Rα, sIL-2Rβ) induce subunit-specific behavioral responses and accumulate in the cerebral cortex and basal forebrain</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e36316</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0036316</pub-id><pub-id pub-id-type="pmid">22558434</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zebardast</surname><given-names>N.</given-names></name><name><surname>Crowley</surname><given-names>M. J.</given-names></name><name><surname>Bloch</surname><given-names>M. H.</given-names></name><name><surname>Mayes</surname><given-names>L. C.</given-names></name><name><surname>Wyk</surname><given-names>B. V.</given-names></name><name><surname>Leckman</surname><given-names>J. F.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Brain mechanisms for prepulse inhibition in adults with tourette syndrome: initial findings</article-title>. <source/>Psychiatry Res.
<volume>214</volume>, <fpage>33</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.pscychresns.2013.05.009</pub-id><pub-id pub-id-type="pmid">23916249</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Siegel</surname><given-names>A.</given-names></name><name><surname>Zalcman</surname><given-names>S. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Anti-streptococcus IgM antibodies induce repetitive stereotyped movements: cell activation and co-localization with Fcα/μ receptors in the striatum and motor cortex</article-title>. <source/>Brain Behav. Immun.
<volume>26</volume>, <fpage>521</fpage>–<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbi.2012.01.005</pub-id><pub-id pub-id-type="pmid">22285613</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Minocycline alleviates behavioral deficits and inhibits microglial activation induced by intrahippocampal administration of granulocyte-macrophage colony-stimulating factor in adult rats</article-title>. <source/>Neuroscience
<volume>266</volume>, <fpage>275</fpage>–<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.01.021</pub-id><pub-id pub-id-type="pmid">24486961</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Spencer</surname><given-names>T. J.</given-names></name><name><surname>Biederman</surname><given-names>J.</given-names></name><name><surname>Bhide</surname><given-names>P. G.</given-names></name></person-group> (<year>2012</year>). <article-title>Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>9410</fpage>–<lpage>9418</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1041-12.2012</pub-id><pub-id pub-id-type="pmid">22764249</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>A. M.</given-names></name><name><surname>Jene</surname><given-names>T.</given-names></name><name><surname>Wolf</surname><given-names>M.</given-names></name><name><surname>Görlich</surname><given-names>A.</given-names></name><name><surname>Gurniak</surname><given-names>C. B.</given-names></name><name><surname>Sassoè-Pognetto</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Attention-deficit/hyperactivity disorder-like phenotype in a mouse model with impaired actin dynamics</article-title>. <source/>Biol. Psychiatry
<volume>78</volume>, <fpage>95</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2014.03.011</pub-id><pub-id pub-id-type="pmid">24768258</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item>
<term>ADHD</term>
<def>
<p>Attention Deficit/Hyperactivity Disorder</p>
</def>
</def-item>
<def-item>
<term>CSTC</term>
<def>
<p>Cortico-striato-thalamo-cortical circuit</p>
</def>
</def-item>
<def-item>
<term>DA</term>
<def>
<p>Dopamine</p>
</def>
</def-item>
<def-item>
<term>DOI, 2</term>
<def>
<p>5-Dymethoxy-4-iodoamphetamine</p>
</def>
</def-item>
<def-item>
<term>DR</term>
<def>
<p>Dopaminergic Receptor</p>
</def>
</def-item>
<def-item>
<term>DSM-5</term>
<def>
<p>Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition</p>
</def>
</def-item>
<def-item>
<term>GABA</term>
<def>
<p>Gamma-Aminobutyric acid</p>
</def>
</def-item>
<def-item>
<term>GPe</term>
<def>
<p>Globus pallidus externus</p>
</def>
</def-item>
<def-item>
<term>HDC</term>
<def>
<p>Histidine decarboxylase</p>
</def>
</def-item>
<def-item>
<term>KO</term>
<def>
<p>Knock-out</p>
</def>
</def-item>
<def-item>
<term>NTs</term>
<def>
<p>Neurotransmitters</p>
</def>
</def-item>
<def-item>
<term>OCD</term>
<def>
<p>Obsessive-Compulsive Disorder</p>
</def>
</def-item>
<def-item>
<term>PPI</term>
<def>
<p>Pre-Pulse Inhibition</p>
</def>
</def-item>
<def-item>
<term>PU</term>
<def>
<p>Premonitory Urge</p>
</def>
</def-item>
<def-item>
<term>TS</term>
<def>
<p>Tourette's Syndrome.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>